Cover
Cover - shares | 9 Months Ended | |
Sep. 30, 2023 | Nov. 10, 2023 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Document Period End Date | Sep. 30, 2023 | |
Document Fiscal Period Focus | Q3 | |
Document Fiscal Year Focus | 2023 | |
Current Fiscal Year End Date | --12-31 | |
Entity File Number | 000-55575 | |
Entity Registrant Name | SIGYN THERAPEUTICS, INC. | |
Entity Central Index Key | 0001642159 | |
Entity Tax Identification Number | 47-2573116 | |
Entity Incorporation, State or Country Code | DE | |
Entity Address, Address Line One | 2468 Historic Decatur Road Ste. | |
Entity Address, Address Line Two | 140 | |
Entity Address, City or Town | San Diego | |
Entity Address, State or Province | CA | |
Entity Address, Postal Zip Code | 92106 | |
City Area Code | (619) | |
Local Phone Number | 353-0800 | |
Title of 12(g) Security | Common Stock, $0.0001 Par Value | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Elected Not To Use the Extended Transition Period | true | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 51,536,602 |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) | Sep. 30, 2023 | Dec. 31, 2022 |
Current assets: | ||
Cash | $ 64,584 | $ 8,356 |
Inventories | 50,000 | 50,000 |
Other current assets | 54,287 | 11,942 |
Total current assets | 168,871 | 70,298 |
Property and equipment, net | 16,906 | 22,052 |
Intangible assets, net | 2,100 | |
Operating lease right-of-use assets, net | 180,735 | 217,718 |
Other assets | 20,711 | 20,711 |
Total assets | 387,223 | 332,879 |
Current liabilities: | ||
Accounts payable | 361,629 | 327,517 |
Accrued payroll and payroll taxes | 405,248 | 30,124 |
Advance from shareholder | 45,000 | |
Short-term convertible notes payable, less unamortized debt issuance costs of $838,084 and $642,660, respectively | 2,947,751 | 1,636,656 |
Current portion of operating lease liabilities | 59,061 | 53,200 |
Other current liabilities | 1,807 | 1,197 |
Total current liabilities | 3,820,496 | 2,048,694 |
Long-term liabilities: | ||
Operating lease liabilities, net of current portion | 142,398 | 187,425 |
Total long-term liabilities | 142,398 | 187,425 |
Total liabilities | 3,962,894 | 2,236,119 |
Stockholders’ deficit: | ||
Preferred stock, $0.0001 par value, 10,000,000 shares authorized; 1,287 and none shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively | ||
Common stock, $0.0001 par value, 1,000,000,000 shares authorized; 44,236,260 and 38,263,813 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively | 4,424 | 3,826 |
Additional paid-in capital | 6,585,367 | 5,288,510 |
Accumulated deficit | (10,165,462) | (7,195,576) |
Total stockholders’ deficit | (3,575,671) | (1,903,240) |
Total liabilities and stockholders’ deficit | $ 387,223 | $ 332,879 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) | Sep. 30, 2023 | Dec. 31, 2022 |
Statement of Financial Position [Abstract] | ||
Unamortized debt issuance costs | $ 838,084 | $ 642,660 |
Preferred stock, par value | $ 0.0001 | $ 0.0001 |
Preferred stock, shares authorized | 10,000,000 | 10,000,000 |
Preferred stock, shares issued | 1,287 | 0 |
Preferred stock, shares outstanding | 1,287 | 0 |
Common stock, par value | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized | 1,000,000,000 | 1,000,000,000 |
Common stock, shares issued | 44,236,260 | 38,263,813 |
Common stock, shares outstanding | 44,236,260 | 38,263,813 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Income Statement [Abstract] | ||||
Net revenues | ||||
Gross Profit | ||||
Operating expenses: | ||||
Marketing expenses | 51 | 65 | 335 | 446 |
Stock based compensation | 37,500 | 112,500 | ||
Research and development | 215,230 | 133,770 | 582,232 | 516,796 |
General and administrative | 390,033 | 399,812 | 1,043,014 | 1,158,435 |
Total operating expenses | 642,814 | 533,647 | 1,738,081 | 1,675,677 |
Loss from operations | (642,814) | (533,647) | (1,738,081) | (1,675,677) |
Other expense: | ||||
Modification of warrants | (2,567) | (226,929) | ||
Interest expense | 670 | 70 | 2,300 | 102 |
Interest expense - debt discount | 220,854 | 148,372 | 1,309,703 | 309,226 |
Interest expense - original issuance costs | 43,955 | 44,420 | 146,731 | 85,875 |
Total other expense | 262,912 | 192,862 | 1,231,805 | 395,203 |
Loss before income taxes | (905,726) | (726,509) | (2,969,886) | (2,070,880) |
Income taxes | ||||
Net loss | $ (905,726) | $ (726,509) | $ (2,969,886) | $ (2,070,880) |
Net loss per share, basic | $ (0.02) | $ (0.02) | $ (0.07) | $ (0.06) |
Net loss per share, diluted | $ (0.02) | $ (0.02) | $ (0.07) | $ (0.06) |
Weighted average number of shares outstanding, basic | 44,233,778 | 37,295,813 | 42,031,295 | 37,295,813 |
Weighted average number of shares outstanding, diluted | 44,233,778 | 37,295,813 | 42,031,295 | 37,295,813 |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Stockholders' Deficit (Unaudited) - USD ($) | Preferred Stock [Member] | Common Stock [Member] | Additional Paid-in Capital [Member] | Retained Earnings [Member] | Total |
Beginning balance, value at Dec. 31, 2021 | $ 3,730 | $ 3,997,445 | $ (4,265,759) | $ (264,584) | |
Beginning balance, shares at Dec. 31, 2021 | 37,295,803 | ||||
Warrants issued to third parties in conjunction with debt issuance | 162,362 | 162,362 | |||
Amortization of warrants issued in connection with a debt modification | 48,699 | 48,699 | |||
Net loss | (678,046) | (678,046) | |||
Ending balance, value at Mar. 31, 2022 | $ 3,730 | 4,208,506 | (4,943,805) | (731,569) | |
Ending balance, shares at Mar. 31, 2022 | 37,295,803 | ||||
Beginning balance, value at Dec. 31, 2021 | $ 3,730 | 3,997,445 | (4,265,759) | (264,584) | |
Beginning balance, shares at Dec. 31, 2021 | 37,295,803 | ||||
Net loss | (2,070,880) | ||||
Ending balance, value at Sep. 30, 2022 | $ 3,730 | 4,590,807 | (6,336,639) | (1,742,102) | |
Ending balance, shares at Sep. 30, 2022 | 37,295,803 | ||||
Beginning balance, value at Mar. 31, 2022 | $ 3,730 | 4,208,506 | (4,943,805) | (731,569) | |
Beginning balance, shares at Mar. 31, 2022 | 37,295,803 | ||||
Warrants issued to third parties in conjunction with debt issuance | 168,991 | 168,991 | |||
Amortization of warrants issued in connection with a debt modification | 49,240 | 49,240 | |||
Net loss | (666,325) | (666,325) | |||
Fees associated with filing of Form S-1 | (3,498) | (3,498) | |||
Ending balance, value at Jun. 30, 2022 | $ 3,730 | 4,423,239 | (5,610,130) | (1,183,161) | |
Ending balance, shares at Jun. 30, 2022 | 37,295,803 | ||||
Warrants issued to third parties in conjunction with debt issuance | 157,787 | 157,787 | |||
Amortization of warrants issued in connection with a debt modification | 49,781 | 49,781 | |||
Net loss | (726,509) | (726,509) | |||
Fees associated with filing of Form S-1 | (40,000) | (40,000) | |||
Ending balance, value at Sep. 30, 2022 | $ 3,730 | 4,590,807 | (6,336,639) | (1,742,102) | |
Ending balance, shares at Sep. 30, 2022 | 37,295,803 | ||||
Beginning balance, value at Dec. 31, 2022 | $ 3,826 | 5,288,510 | (7,195,576) | (1,903,240) | |
Beginning balance, shares at Dec. 31, 2022 | 38,263,813 | ||||
Warrants issued to third parties in conjunction with debt issuance | 578,016 | 578,016 | |||
Net loss | (1,341,036) | (1,341,036) | |||
Fees associated with filing of Form S-1 | (5,456) | (5,456) | |||
Beneficial conversion feature in conjunction with debt issuance | 303,984 | 303,984 | |||
Stock based compensation | 37,500 | 37,500 | |||
Modification of warrants | $ 455 | (16,261) | (15,806) | ||
Modification of warrants, shares | 4,541,012 | ||||
Ending balance, value at Mar. 31, 2023 | $ 4,281 | 6,186,293 | (8,536,612) | (2,346,038) | |
Ending balance, shares at Mar. 31, 2023 | 42,804,825 | ||||
Beginning balance, value at Dec. 31, 2022 | $ 3,826 | 5,288,510 | (7,195,576) | (1,903,240) | |
Beginning balance, shares at Dec. 31, 2022 | 38,263,813 | ||||
Net loss | (2,969,886) | ||||
Ending balance, value at Sep. 30, 2023 | $ 4,424 | 6,585,367 | (10,165,462) | (3,575,671) | |
Ending balance, shares at Sep. 30, 2023 | 1,287 | 44,236,260 | |||
Beginning balance, value at Mar. 31, 2023 | $ 4,281 | 6,186,293 | (8,536,612) | (2,346,038) | |
Beginning balance, shares at Mar. 31, 2023 | 42,804,825 | ||||
Net loss | (723,124) | (723,124) | |||
Stock based compensation | 37,500 | 37,500 | |||
Modification of warrants | $ 629 | (209,185) | (208,556) | ||
Modification of warrants, shares | 6,289,105 | ||||
Conversion of common stock for Series A preferred stock | $ (611) | 611 | |||
Conversion of common stock for Series A preferred stock, shares | 1,215 | (6,105,528) | |||
Common stock issued to third parties in conjunction with conversion of debt | $ 124 | 197,876 | 198,000 | ||
Common stock issued to third parties in conjunction with conversion of debt, shares | 1,243,000 | ||||
Ending balance, value at Jun. 30, 2023 | $ 4,423 | 6,213,095 | (9,259,736) | (3,042,218) | |
Ending balance, shares at Jun. 30, 2023 | 1,215 | 44,231,402 | |||
Warrants issued to third parties in conjunction with debt issuance | 255,692 | 255,692 | |||
Net loss | (905,726) | (905,726) | |||
Beneficial conversion feature in conjunction with debt issuance | 81,647 | 81,647 | |||
Stock based compensation | 37,500 | 37,500 | |||
Modification of warrants | $ 37 | (2,603) | (2,566) | ||
Modification of warrants, shares | 366,667 | ||||
Conversion of common stock for Series A preferred stock | $ (36) | 36 | |||
Conversion of common stock for Series A preferred stock, shares | 72 | (361,809) | |||
Ending balance, value at Sep. 30, 2023 | $ 4,424 | $ 6,585,367 | $ (10,165,462) | $ (3,575,671) | |
Ending balance, shares at Sep. 30, 2023 | 1,287 | 44,236,260 |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) | 9 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Cash flows from operating activities: | ||
Net loss | $ (2,969,886) | $ (2,070,880) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Depreciation expense | 5,146 | 5,139 |
Amortization expense | 2,100 | 2,700 |
Stock based compensation | 112,500 | |
Accretion of debt discount | 1,309,703 | 309,226 |
Accretion of original issuance costs | 146,731 | 85,875 |
Modification of warrants | (226,929) | |
Changes in operating assets and liabilities: | ||
Other current assets | (42,345) | (5,179) |
Accounts payable | 34,112 | 266,147 |
Accrued payroll and payroll taxes | 375,124 | 29,052 |
Other current liabilities | (1,572) | (555) |
Net cash used in operating activities | (1,255,316) | (1,378,475) |
Cash flows from investing activities: | ||
Purchase of property and equipment | (860) | |
Net cash used in investing activities | (860) | |
Cash flows from financing activities: | ||
Proceeds from short-term convertible notes | 1,272,000 | 1,110,000 |
Advance from shareholder | 45,000 | |
Fees associated with filing of Form S-1 | (5,456) | (43,498) |
Net cash provided by financing activities | 1,311,544 | 1,066,502 |
Net (decrease) increase in cash | 56,228 | (312,833) |
Cash at beginning of period | 8,356 | 340,956 |
Cash at end of period | 64,584 | 28,123 |
Cash paid during the period for: | ||
Interest | ||
Income taxes | ||
Non-cash investing and financing activities: | ||
Beneficial conversion feature in conjunction with debt issuance | 385,631 | |
Warrants issued to third parties in conjunction with debt issuance | 833,708 | 331,353 |
Original issue discount issued in conjunction with debt | 127,200 | 52,500 |
Original issue discount issued in conjunction with extension of debt | 305,319 | |
Common stock issued to third parties in conjunction with conversion of debt | 198,000 | |
Conversion of common stock for Series A preferred stock | 647 | |
Amortization of warrants issued in connection with a debt modification | $ 97,939 |
ORGANIZATION AND PRINCIPAL ACTI
ORGANIZATION AND PRINCIPAL ACTIVITIES | 9 Months Ended |
Sep. 30, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
ORGANIZATION AND PRINCIPAL ACTIVITIES | NOTE 1 – ORGANIZATION AND PRINCIPAL ACTIVITIES Corporate History and Background Sigyn Therapeutics, Inc. (“Sigyn”, the “Company” “we,” “us,” or “our”) is a development-stage company that creates blood purification technologies to overcome clearly defined limitations in healthcare. Sigyn Therapy™, our lead product candidate, is being advanced to treat life-threatening conditions that are not addressed with market-cleared drug agents. Candidate treatment indications include endotoxemia, sepsis (a leading cause of hospital deaths), community acquired pneumonia (a leading cause of infectious disease deaths), drug-resistant bacterial infections, and emerging pandemic viral threats. Our therapeutic pipeline is comprised of technologies that we have designed to improve the targeted delivery of cancer drug agents. ChemoPrep TM TM TM Merger Transaction On October 19, 2020, Sigyn Therapeutics, Inc, a Delaware corporation (the “Registrant”) formerly known as Reign Resources Corporation, completed a Share Exchange Agreement (the “Agreement”) with Sigyn Therapeutics, Inc., a private entity incorporated in the State of Delaware on October 19, 2019. In the Share Exchange Agreement, we acquired 100 75 75 3,429,516 7,907,351 |
BASIS OF PRESENTATION
BASIS OF PRESENTATION | 9 Months Ended |
Sep. 30, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
BASIS OF PRESENTATION | NOTE 2 – BASIS OF PRESENTATION The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and include all adjustments necessary for the fair presentation of the Company’s financial position and results of operations for the periods presented. The Company currently operates in one business segment. The Company is not organized by market and is managed and operated as one business. A single management team reports to the chief operating decision maker, the Chief Executive Officer, who comprehensively manages the entire business. The Company does not currently operate any separate lines of businesses or separate business entities. Going Concern The accompanying financial statements have been prepared assuming the Company will continue as a going concern, which contemplates, among other things, the realization of assets and satisfaction of liabilities in the normal course of business. The Company had an accumulated deficit of $ 10,165,462 3,651,625 905,726 2,969,886 726,509 2,070,880 1,255,316 1,378,475 While the Company is attempting to expand operations and increase revenues, the Company’s cash position may not be significant enough to support the Company’s daily operations. Management intends to raise additional funds by way of a public offering or an asset sale transaction. Management believes that the actions presently being taken to further implement its business plan and generate revenues provide the opportunity for the Company to continue as a going concern. While management believes in the viability of its strategy to generate revenues and in its ability to raise additional funds or transact an asset sale, there can be no assurances to that effect or on terms acceptable to the Company. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further implement its business plan and generate revenues. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern for a year from the date of issuance. |
SUMMARY OF SIGNIFICANT ACCOUNTI
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 9 Months Ended |
Sep. 30, 2023 | |
Accounting Policies [Abstract] | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES This summary of significant accounting policies of the Company is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to GAAP and have been consistently applied in the preparation of the financial statements. Use of Estimates The preparation of these financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the financial statements and the reported amounts of net sales and expenses during the reported periods. Actual results may differ from those estimates and such differences may be material to the financial statements. The more significant estimates and assumptions by management relate to common stock valuation. The current economic environment has increased the degree of uncertainty inherent in these estimates and assumptions. Cash The Company’s cash is held in bank accounts in the United States and is insured by the Federal Deposit Insurance Corporation (FDIC) up to $ 250,000 Income Taxes Income taxes are accounted for under an asset and liability approach. This process involves calculating the temporary and permanent differences between the carrying amounts of the assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The temporary differences result in deferred tax assets and liabilities, which would be recorded on the Balance Sheets in accordance with ASC 740, which established financial accounting and reporting standards for the effect of income taxes. The likelihood that its deferred tax assets will be recovered from future taxable income must be assessed and, to the extent that recovery is not likely, a valuation allowance is established. Changes in the valuation allowance in a period are recorded through the income tax provision in the consolidated Statements of Operations. ASC 740-10 clarifies the accounting for uncertainty in income taxes recognized in an entity’s consolidated financial statements and prescribes a recognition threshold and measurement attributes for financial statement disclosure of tax positions taken or expected to be taken on a tax return. Under ASC 740-10, the impact of an uncertain income tax position on the income tax return must be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Additionally, ASC 740-10 provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. As a result of the implementation of ASC 740-10 and currently, the Company does not have a liability for unrecognized income tax benefits. Advertising and Marketing Costs Advertising expenses are recorded as general and administrative expenses when they are incurred. The Company had $ 51 335 65 446 Research and Development All research and development costs are expensed as incurred. The Company incurred research and development expense of $ 215,230 582,232 133,770 516,796 Inventories In conjunction with the October 19, 2020 Share Exchange Agreement, the Company kept the gem inventory of Reign Resources Corporation. Inventories are stated at the lower of cost or market (net realizable value) on a lot basis each quarter. A lot is determined by the cut, clarity, size, and weight of the sapphires. Inventory consists of sapphire jewels that meet rigorous grading criteria and are of cuts and sizes most commonly used in the jewelry industry. As of September 30, 2023 and December 31, 2022, the Company carried primarily loose sapphire jewels, jewelry for sale on our website, and jewelry held as samples. Samples are used to show potential customers what the jewelry would look like. Promotional items given to customers that are not expected to be returned will be removed from inventory and expensed. There have been no promotional items given to customers as of September 30, 2023. The Company performs its own in-house assessment based on gem guide and the current market price for metals to value its inventory on an annual basis or if circumstances dictate sooner to determine if the estimated fair value is greater or less than cost. In addition, the inventory is reviewed each quarter by the Company against industry prices from gem-guide and if there is a potential impairment, the Company would appraise the inventory. The estimated fair value is subject to significant change due to changes in popularity of cut, perceived grade of the clarity of the sapphires, the number, type and size of inclusions, the availability of other similar quality and size sapphires, and other factors. As a result, the internal assessed value of the sapphires could be significantly lower from the current estimated fair value. Loose sapphire jewels do not degrade in quality over time. Property and Equipment Property and equipment are carried at cost and are depreciated on a straight-line basis over the estimated useful lives of the assets, generally five years Intangible Assets Intangible assets consist primarily of website development costs. Our intangible assets are being amortized on a straight-line basis over a period of three years. Impairment of Long-lived Assets We periodically evaluate whether the carrying value of property, equipment and intangible assets has been impaired when circumstances indicate the carrying value of those assets may not be recoverable. The carrying amount is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. If the carrying value is not recoverable, the impairment loss is measured as the excess of the asset’s carrying value over its fair value. Our impairment analyses require management to apply judgment in estimating future cash flows as well as asset fair values, including forecasting useful lives of the assets, assessing the probability of different outcomes, and selecting the discount rate that reflects the risk inherent in future cash flows. If the carrying value is not recoverable, we assess the fair value of long-lived assets using commonly accepted techniques, and may use more than one method, including, but not limited to, recent third-party comparable sales and discounted cash flow models. If actual results are not consistent with our assumptions and estimates, or our assumptions and estimates change due to new information, we may be exposed to an impairment charge in the future. As of September 30, 2023 and December 31, 2022, the Company had not experienced impairment losses on its long-lived assets. Fair Value of Financial Instruments The provisions of accounting guidance, FASB Topic ASC 825 requires all entities to disclose the fair value of financial instruments, both assets and liabilities recognized and not recognized on the balance sheet, for which it is practicable to estimate fair value, and defines fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties. As of September 30, 2023 and December 31, 2022, the fair value of cash, accounts payable, accrued expenses, and notes payable approximated carrying value due to the short maturity of the instruments, quoted market prices or interest rates which fluctuate with market rates. Fair Value Measurements Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, as follows: ● Level 1 – Quoted prices in active markets for identical assets or liabilities. ● Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. ● Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities The carrying value of financial assets and liabilities recorded at fair value are measured on a recurring or nonrecurring basis. Financial assets and liabilities measured on a non-recurring basis are those that are adjusted to fair value when a significant event occurs. There were no financial assets or liabilities carried and measured on a nonrecurring basis during the reporting periods. Financial assets and liabilities measured on a recurring basis are those that are adjusted to fair value each time a financial statement is prepared. There have been no transfers between levels. Debt The Company issues debt that may have separate warrants, conversion features, or no equity-linked attributes. Embedded Conversion Features The Company evaluates embedded conversion features within convertible debt under ASC 815, Derivatives and Hedging, Debt with Conversion and Other Options Derivative Financial Instruments The Company evaluates all of its financial instruments, including stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported as charges or credits to income. For option-based simple derivative financial instruments, the Company uses the Monte Carlo simulations to value the derivative instruments at inception and subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. There were no derivative financial instruments as of September 30, 2023 and December 31, 2022 and no charges or credits to income for the three and nine months ended September 30, 2023 and 2022. Debt Issue Costs and Debt Discount The Company may record debt issue costs and/or debt discounts in connection with raising funds through the issuance of debt. These costs may be paid in the form of cash or equity (such as warrants). These costs are amortized to interest expense through the maturity of the debt. If a conversion of the underlying debt occurs prior to maturity a proportionate share of the unamortized amounts is immediately expensed. Any unamortized debt issue costs and debt discount are presented net of the related debt on the consolidated balance sheets. Original Issue Discount For certain convertible debt issued, the Company may provide the debt holder with an original issue discount. The original issue discount would be recorded to debt discount, reducing the face amount of the note and is amortized to interest expense through the maturity of the debt. If a conversion of the underlying debt occurs prior to maturity a proportionate share of the unamortized amounts is immediately expensed. Any unamortized original issue discounts are presented net of the related debt on the consolidated balance sheets. If the conversion feature does not qualify for either the derivative treatment or as a beneficial conversion feature, the convertible debt is treated as traditional debt. Basic and diluted earnings per share Basic net loss per share is calculated by dividing the net loss by the weighted-average number of common shares outstanding for the period, without consideration for common stock equivalents. Diluted earnings (loss) per share are computed on the basis of the weighted average number of common shares (including common stock subject to redemption) plus dilutive potential common shares outstanding for the reporting period. In periods where losses are reported, the weighted-average number of common stock outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. Basic and diluted earnings (loss) per share are the same since net losses for all periods presented and including the additional potential common shares would have an anti-dilutive effect. Stock Based Compensation In accordance with ASC No. 718, Compensation – Stock Compensation Non-Employee Stock-Based Compensation In accordance with ASC 505, Equity Based Payments to Non-Employees, Concentrations, Risks, and Uncertainties Business Risk Substantial business risks and uncertainties are inherent to an entity, including the potential risk of business failure. The Company is headquartered and operates in the United States. To date, the Company has generated no revenues from operations. There can be no assurance that the Company will be able to raise additional capital and failure to do so would have a material adverse effect on the Company’s financial position, results of operations and cash flows. Also, the success of the Company’s operations is subject to numerous contingencies, some of which are beyond management’s control. Currently, these contingencies include general economic conditions, price of components, competition, and governmental and political conditions. Interest rate risk Financial assets and liabilities do not have material interest rate risk. Credit risk The Company is exposed to credit risk from its cash in banks. The credit risk on cash in banks is limited because the counterparties are recognized financial institutions. Seasonality The business is not subject to substantial seasonal fluctuations. Major Suppliers Sigyn Therapy is comprised of components that are supplied by various industry vendors. Additionally, the Company is reliant on third-party organizations to conduct clinical development studies that are necessary to advance Sigyn Therapy toward the marketplace. Should the relationship with an industry vendor or third-party clinical development organization be interrupted or discontinued, it is believed that alternate component suppliers and third-party clinical development organizations could be identified to support the continued advancement of Sigyn Therapy. Recent Accounting Pronouncements There are no recently issued accounting updates that are expected to have a material impact on the Company’s consolidated financial statements. |
PROPERTY AND EQUIPMENT
PROPERTY AND EQUIPMENT | 9 Months Ended |
Sep. 30, 2023 | |
Property, Plant and Equipment [Abstract] | |
PROPERTY AND EQUIPMENT | NOTE 4 – PROPERTY AND EQUIPMENT Property and equipment consisted of the following as of: SCHEDULE OF PROPERTY AND EQUIPMENT Estimated Life September 30, 2023 December 31, 2022 Office equipment 5 years $ 30,410 $ 29,041 Computer equipment 3 years 3,157 3,157 Property and equipment, gross 3 years 3,157 3,157 Accumulated depreciation (15,292 ) (10,146 ) Property and equipment, net $ 16,906 $ 22,052 Depreciation expense was $ 1,716 5,146 1,716 5,139 |
INTANGIBLE ASSETS
INTANGIBLE ASSETS | 9 Months Ended |
Sep. 30, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
INTANGIBLE ASSETS | NOTE 5 – INTANGIBLE ASSETS Intangible assets consisted of the following as of: SCHEDULE OF INTANGIBLE ASSETS Estimated life September 30, 2023 December 31, 2022 Website 3 years $ 10,799 $ 10,799 Accumulated amortization (10,799 ) (8,699 ) Intangible assets, net $ - $ 2,100 The Company had amortization expense of $ 300 2,100 900 2,700 |
CONVERTIBLE PROMISSORY DEBENTUR
CONVERTIBLE PROMISSORY DEBENTURES | 9 Months Ended |
Sep. 30, 2023 | |
Debt Disclosure [Abstract] | |
CONVERTIBLE PROMISSORY DEBENTURES | NOTE 6 – CONVERTIBLE PROMISSORY DEBENTURES Convertible notes payable consisted of the following: SCHEDULE OF CONVERTIBLE NOTES PAYABLE September 30, 2023 December 31, 2022 January 28, 2020 ($564,138) – 0% interest per annum outstanding principal and interest due August 30, 2024 (“Note 1”) $ 564,138 $ 457,380 January 28, 2020 ($ 564,138 0 August 30, 2024 $ 564,138 $ 457,380 June 23, 2020 ($ 74,621 0 August 30, 2024 74,621 60,500 September 17, 2020 ($ 225,377 0 August 30, 2024 16,714 199,650 42,857 225,377 182,936 March 23, 2022 ($ 259,685 0 August 30, 2024 259,685 220,000 April 28, 2022 ($ 127,979 0 August 30, 2024 127,979 110,000 May 10, 2022 ($ 128,020 0 August 30, 2024 128,020 110,000 June 1, 2022 ($ 63,301 0 August 30, 2024 63,301 55,000 June 22, 2022 ($ 94,314 0 August 30, 2024 94,314 82,500 July 2022 ($ 341,000 0 July 2023 16,500 33,000 324,500 341,000 August 31, 2022 ($ 123,200 0 August 30, 2024 123,200 110,000 September 9, 2022 ($ 92,400 0 August 30, 2024 92,400 82,500 September 20, 2022 ($ 123,200 0 August 30, 2024 123,200 110,000 October 20, 2022 ($ 110,000 0 October 20, 2023 110,000 110,000 November 9, 2022 ($ 92,400 0 August 30, 2024 92,400 82,500 November 14, 2022 ($ 55,000 0 November 14, 2023 55,000 55,000 December 22, 2022 ($ 110,000 0 December 22, 2023 110,000 110,000 During the three and nine months ended September 30, 2023 ($ 1,399,200 0 September 1, 2024 181,500 1,210,000 1,217,700 - Total convertible notes payable 3,785,835 2,279,316 Original issue discount (360,290 ) (74,502 ) Beneficial conversion feature (191,842 ) (175,275 ) Debt discount (285,952 ) (392,883 ) Total convertible notes payable $ 2,947,751 $ 1,636,656 Principal payments on convertible promissory debentures are due as follows: SCHEDULE OF PRINCIPAL PAYMENTS DUE ON CONVERTIBLE PROMISSORY DEBENTURES Year ending December 31, 2023 (6 months remaining) $ 599,500 2024 $ 3,186,336 Long-Term Debt $ 3,785,836 Changes in convertible notes were as follows: SCHEDULE OF CHANGES IN CONVERTIBLE NOTES Note 1 Note 2 Note 3 Note 4 Note 5 Note 6 Note 7 Note 8 Note 9 Note 10 Note 11 Note 12 Note 13 Note 14 Note 15 Note 16 Note 17 Other Totals Convertible notes payable, net, as of December 31, 2021 457,380 60,500 182,936 - - - - - - - - - - - - - - - 700,816 Convertible notes payable issued in 2022 - - - 220,000 110,000 110,000 55,000 82,500 341,000 110,000 82,500 110,000 110,000 82,500 55,000 110,000 - - 1,578,500 Convertible notes payable as of December 31, 2022 $ 457,380 $ 60,500 $ 182,936 $ 220,000 $ 110,000 $ 110,000 $ 55,000 $ 82,500 $ 341,000 $ 110,000 $ 82,500 $ 110,000 $ 110,000 $ 82,500 $ 55,000 $ 110,000 $ - $ - $ 2,279,316 Convertible notes payable issued in 2023 106,758 14,121 42,441 39,685 17,979 18,020 8,301 11,814 - 13,200 9,900 13,200 - 9,900 - - 1,399,200 - 1,704,519 Conversion of debt for common stock - - - - - - - - (16,500 ) - - - - - - - (181,500 ) - (198,000 ) Convertible notes payable as of September 30, 2023 $ 564,138 $ 74,621 $ 225,377 $ 259,685 $ 127,979 $ 128,020 $ 63,301 $ 94,314 $ 324,500 $ 123,200 $ 92,400 $ 123,200 $ 110,000 $ 92,400 $ 55,000 $ 110,000 $ 1,217,700 $ - $ 3,785,835 Changes in note discounts were as follows: SCHEDULE OF CHANGES IN NOTE DISCOUNTS Note 1 Note 2 Note 3 Note 4 Note 5 Note 6 Note 7 Note 8 Note 9 Note 10 Note 11 Note 12 Note 13 Note 14 Note 15 Note 16 Note 17 Other Totals Note discounts as of December 31, 2021 34,176 4,521 14,917 - - - - - - - - - - - - - - - 53,614 Note discounts issued in conjunction with debt in 2022 - - - 113,418 44,786 44,787 22,794 34,861 140,289 64,104 82,500 110,000 110,000 82,500 55,000 110,000 - - 1,015,039 2022 accretion of note discounts (34,176 ) (4,521 ) (14,917 ) (87,938 ) (30,308 ) (28,836 ) (13,301 ) (18,336 ) (70,720 ) (32,316 ) (39,994 ) (49,874 ) (23,671 ) (12,822 ) (7,726 ) (6,537 ) - 50,000 (425,993 ) Note discounts as of December 31, 2022 $ - $ - $ - $ 25,480 $ 14,478 $ 15,951 $ 9,493 $ 16,525 $ 69,569 $ 31,788 $ 42,506 $ 60,126 $ 86,329 $ 69,678 $ 47,274 $ 103,463 $ - $ 50,000 $ 642,660 Note discounts issued in conjunction with debt in 2023 106,758 14,121 42,441 39,685 17,979 18,020 8,301 11,814 - 13,200 9,900 13,200 - 9,900 - - 1,346,539 - 1,651,858 2023 accretion of note discounts (4,680 ) (619 ) (1,860 ) (27,220 ) (15,267 ) (16,741 ) (9,857 ) (17,043 ) (69,569 ) (32,367 ) (42,939 ) (60,705 ) (79,756 ) (60,250 ) (39,877 ) (79,754 ) (847,930 ) (50,000 ) (1,456,434 ) Note discounts as of September 30, 2023 $ 102,078 $ 13,502 $ 40,581 $ 37,945 $ 17,190 $ 17,230 $ 7,937 $ 11,296 $ - $ 12,621 $ 9,467 $ 12,621 $ 6,573 $ 19,328 $ 7,397 $ 23,709 $ 498,609 $ - $ 838,084 Convertible notes payable, net, as of December 31, 2021 $ 423,204 $ 55,979 $ 168,019 $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ 647,202 Convertible notes payable, net, as of December 31, 2022 $ 457,380 $ 60,500 $ 182,936 $ 194,520 $ 95,522 $ 94,049 $ 45,507 $ 65,975 $ 271,431 $ 78,212 $ 39,994 $ 49,874 $ 23,671 $ 12,822 $ 7,726 $ 6,537 $ - $ (50,000 ) $ 1,636,656 Convertible notes payable, net, as of September 30, 2023 $ 462,060 $ 61,119 $ 184,796 $ 221,740 $ 110,789 $ 110,790 $ 55,364 $ 83,018 $ 324,500 $ 110,579 $ 82,933 $ 110,579 $ 103,427 $ 73,072 $ 47,603 $ 86,291 $ 719,091 $ - $ 2,947,751 2021 Effective interest rate 11 % 11 % 12 % - - - - - - - - - - - - - - - - 2022 Effective interest rate 7 % 7 % 8 % 40 % 28 % 26 % 24 % 22 % 21 % 29 % 48 % 45 % 22 % 16 % 14 % 6 % - - 19 % 2023 Effective interest rate 1 % 1 % 1 % 10 % 12 % 13 % 16 % 18 % 21 % 26 % 46 % 49 % 73 % 65 % 73 % 73 % 70 % - 38 % Current Noteholders 2023 Notes – $1,399,200 (Note 17) During the nine months ended September 30, 2023, the Company entered into an Original Issue Discount Senior Convertible Debentures (the “2023 Notes”) with third party investors totaling (i) $ 1,399,200 January 2024 through September 1, 2024 five 9,328,010 0.25 1,272,000 127,200 0.15 On June 2, 2023, a third party investor elected to convert $ 181,500 1,210,000 Osher – $110,000 (Note 16) On December 22, 2022, the Company entered into an Original Issue Discount Senior Convertible Debenture (the “Note”) with respect to the sale and issuance to institutional investor Osher Capital Partners LLC (“Osher”) of (i) $ 110,000 December 22, 2023 five 733,333 0.25 100,000 10,000 0.15 Osher – $55,000 (Note 15) On November 14, 2022, the Company entered into an Original Issue Discount Senior Convertible Debenture (the “Note”) with respect to the sale and issuance to institutional investor Osher Capital Partners LLC (“Osher”) of (i) $ 55,000 November 14, 2023 five 366,667 0.25 50,000 5,000 0.15 Brio – $92,400 (Note 14) On November 9, 2022, the Company entered into an Original Issue Discount Senior Convertible Debenture (the “Note”) with respect to the sale and issuance to institutional investor Brio Capital Master Fund Ltd (“Brio”) of (i) $ 82,500 November 9, 2023 five 550,000 0.25 75,000 7,500 0.15 On September 14, 2023, Osher agreed to extend the note to August 30, 2024 for original issue discount of $ 9,900 Osher – $110,000 (Note 13) On October 20, 2022, the Company entered into an Original Issue Discount Senior Convertible Debenture (the “Note”) with respect to the sale and issuance to institutional investor Osher Capital Partners LLC (“Osher”) of (i) $ 110,000 October 20, 2023 733,333 0.25 100,000 10,000 0.15 Osher – $123,200 (Note 12) On September 20, 2022, the Company entered into an Original Issue Discount Senior Convertible Debenture (the “Note”) with respect to the sale and issuance to institutional investor Osher Capital Partners LLC (“Osher”) of (i) $ 110,000 September 20, 2023 five 733,333 0.25 100,000 10,000 0.15 On September 14, 2023, Osher agreed to extend the note to August 30, 2024 for original issue discount of $ 13,200 Brio – $92,400 (Note 11) On September 9, 2022, the Company entered into an Original Issue Discount Senior Convertible Debenture (the “Note”) with respect to the sale and issuance to institutional investor Brio Capital Master Fund Ltd. (“Brio”) of (i) $ 82,500 September 9, 2023 550,000 0.25 75,000 7,500 0.15 On September 14, 2023, Osher agreed to extend the note to August 30, 2024 for original issue discount of $ 9,900 Osher – $123,200 (Note 10) On August 31, 2022, the Company entered into an Original Issue Discount Senior Convertible Debenture (the “Note”) with respect to the sale and issuance to institutional investor Osher Capital Partners LLC (“Osher”) of (i) $ 110,000 August 31, 2023 733,333 0.25 100,000 10,000 0.15 On September 14, 2023, Osher agreed to extend the note to August 30, 2024 for original issue discount of $ 13,200 Other – $341,000 (Note 9) In July 2022, the Company entered into an Original Issue Discount Senior Convertible Debentures (the “July 2022 Notes”) totaling (i) $ 341,000 310,000 July 2023 based on $1.00 for each $0.90909 paid by the noteholder five 676,936 0.50 0.50 The Company has not repaid these convertible notes and the convertible notes are now in default. In October 2023, the noteholders converted their debentures in exchange for the issuance of 649,000 On June 2, 2023, a third party investor elected to convert $ 16,500 33,000 Osher – $94,314 (Note 8) On June 22, 2022, the Company entered into an Original Issue Discount Senior Convertible Debenture (the “Note”) with respect to the sale and issuance to institutional investor Osher Capital Partners LLC (“Osher”) of (i) $ 82,500 June 22, 2023 165,000 0.50 75,000 7,500 0.50 On September 14, 2023, Osher agreed to extend the note to August 30, 2024 for original issue discount of $11,814. Osher – $63,301 (Note 7) On June 1, 2022, the Company entered into an Original Issue Discount Senior Convertible Debenture (the “Note”) with respect to the sale and issuance to institutional investor Osher Capital Partners LLC (“Osher”) of (i) $ 55,000 June 1, 2023 five 110,000 0.50 50,000 5,000 0.50 On September 14, 2023, Osher agreed to extend the note to August 30, 2024 for original issue discount of $ 8,301 Brio – $128,020 (Note 6) On May 10, 2022, the Company entered into an Original Issue Discount Senior Convertible Debenture (the “Note”) with respect to the sale and issuance to institutional investor Brio Capital Master Fund Ltd. (“Brio”) of (i) $ 110,000 May 10, 2023 220,000 0.50 100,000 10,000 0.50 On September 14, 2023, Osher agreed to extend the note to August 30, 2024 for original issue discount of $ 18,020 Osher – $127,979 (Note 5) On April 28, 2022, the Company entered into an Original Issue Discount Senior Convertible Debenture (the “Note”) with respect to the sale and issuance to institutional investor Osher Capital Partners LLC (“Osher”) of (i) $ 110,000 April 28, 2023 220,000 0.50 100,000 10,000 0.50 On September 14, 2023, Osher agreed to extend the note to August 30, 2024 for original issue discount of $ 17,979 Osher – $129,721 (Note 4) On March 23, 2022, the Company entered into an Original Issue Discount Senior Convertible Debenture (the “Note”) with respect to the sale and issuance to institutional investor Osher Capital Partners LLC (“Osher”) of (i) $ 110,000 March 23, 2023 five 220,000 0.50 100,000 10,000 0.50 On September 14, 2023, Osher agreed to extend the note to August 30, 2024 for original issue discount of $ 19,721 Brio – $129,964 (Note 4) On March 23, 2022, the Company entered into an Original Issue Discount Senior Convertible Debenture (the “Note”) with respect to the sale and issuance to institutional investor Brio Capital Master Fund Ltd. (“Brio”) of (i) $ 110,000 March 23, 2023 five 220,000 0.50 100,000 10,000 0.50 On September 14, 2023, Osher agreed to extend the note to August 30, 2024 for original issue discount of $ 19,964 Osher – $225,377 (Note 3) On September 17, 2020 (the “Original Issue Date”), the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with respect to the sale and issuance to institutional investor Osher Capital Partners LLC (“Osher”) of (i) $181,500 aggregate principal amount of Original Issue Discount Senior Convertible Debenture (the “Note”) due September 30, 2021, based on $1.00 for each $0.90909 paid by Osher five 8,250 30.00 165,000 16,500 0.39 The Company and Osher amended the convertible debt agreement as follows on October 20, 2020: ● The parties amended the Warrants dated September 17, 2020, for the number of warrant shares from 8,250 465,366 0.59 ● The parties amended the Note for the maturity date from September 30, 2021 to October 20, 2021 On October 22, 2021, the Company and Osher amended convertible debt agreements as follows: ● The parties amended the October 20, 2020 Notes for the maturity date from October 20, 2021 to October 20, 2022 ● The parties amended the October 20, 2020 Notes for the aggregate principal amount and accrued interest from $ 652,300 717,530 65,230 ● In exchange for the extension of the Note, the Company issued Osher five 450,000 1.00 On October 28, 2021, Osher elected to convert $ 16,714 199,650 42,857 On September 14, 2023, Osher agreed to extend the note to August 30, 2024 for original issue discount of $ 42,441 Osher – $74,621 (Note 2) On June 23, 2020 (the “Original Issue Date”), the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with respect to the sale and issuance to institutional investor Osher Capital Partners LLC (“Osher”) of (i) $ 50,000 June 23, 2021 five 10,000 30.00 50,005 0 0.39 The Company and Osher amended the convertible debt agreement as follows on October 20, 2020: ● The parties amended the Note for the aggregate principal amount from $ 50,000 55,000 50,005 4,995 ● The parties amended the Warrants dated June 23, 2020, for the number of warrant shares from 10,000 141,020 0.59 ● The parties amended the Note for the maturity date from June 23, 2021 to October 20, 2021 On October 22, 2021, the Company and Osher amended convertible debt agreements as follows (see Note 12): ● The parties amended the October 20, 2020 Notes for the maturity date from October 20, 2021 to October 20, 2022 ● The parties amended the October 20, 2020 Notes for the aggregate principal amount and accrued interest from $ 652,300 717,530 65,230 ● In exchange for the extension of the Note, the Company issued Osher five 450,000 1.00 On September 14, 2023, Osher agreed to extend the note to August 30, 2024 for original issue discount of $ 14,121 Osher – $564,138 (Note 1) On January 28, 2020 (the “Original Issue Date”), the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with respect to the sale and issuance to institutional investor Osher Capital Partners LLC (“Osher”) of (i) $ 385,000 January 26, 2021 five 80,209 7.00 350,005 34,995 0.094 The Company and Osher amended the convertible debt agreement as follows on October 20, 2020: ● The parties amended the Warrants dated January 28, 2020, for the number of warrant shares from 80,209 0.14 ● The parties amended the Note to provide for interest at 8 ● The parties amended the Note for the maturity date from June 23, 2021 to October 20, 2021 On October 22, 2021, the Company and Osher amended convertible debt agreements as follows: ● The parties amended the October 20, 2020 Notes for the maturity date from October 20, 2021 to October 20, 2022 ● The parties amended the October 20, 2020 Notes for the aggregate principal amount and accrued interest from $ 652,300 717,530 65,230 ● In exchange for the extension of the Note, the Company issued Osher five 450,000 1.00 The Company has not repaid this convertible note and the convertible note is now in default. On September 14, 2023, Osher agreed to extend the note to August 30, 2024 for original issue discount of $ 106,758 Previous Noteholders Other – $145,200 On November 21, 2022, the Company entered into an Original Issue Discount Senior Convertible Debenture (the “Note”) with a third party investor of (i) $ 145,200 November 21, 2023 five 968,000 0.25 132,000 13,200 0.15 On November 23, 2022, third party investor elected to convert the aggregate principal amount of the Note, $ 145,200 968,000 All other previous notes were detailed in our Form 10-K filed on March 31, 2023. No changes occurred related to these notes during the period covered by this Form 10-Q. |
ADVANCE FROM SHAREHOLDER
ADVANCE FROM SHAREHOLDER | 9 Months Ended |
Sep. 30, 2023 | |
Advance From Shareholder | |
ADVANCE FROM SHAREHOLDER | NOTE 7 – ADVANCE FROM SHAREHOLDER The Company borrows funds from the Company’s CEO for working capital purposes from time to time. The Company has recorded the principal balance due of $ 45,000 0 45,000 0 no |
STOCKHOLDERS_ DEFICIT
STOCKHOLDERS’ DEFICIT | 9 Months Ended |
Sep. 30, 2023 | |
Equity [Abstract] | |
STOCKHOLDERS’ DEFICIT | NOTE 8 – STOCKHOLDERS’ DEFICIT Preferred Stock The Company authorized 10,000,000 0.0001 1,287 none During fiscal 2023, holders of 6,467,337 1,287 Each Series A Convertible Preferred Share converts into one thousand (1,000) shares of the Company’s common stock Rights and Privileges Rights - Voting Rights - Rank - Conversion Rights - Redemption Rights – Common Stock The Company has authorized 1,000,000,000 0.0001 44,236,260 38,263,813 During the nine months ended September 30, 2023, a total of 22,393,561 11,196,784 On June 2, 2023, a third party investor elected to convert the aggregate principal amount of two Notes of $ 198,000 1,243,000 Restricted Stock Units Effective October 10, 2022, the Company’s Board of Directors appointed Ms. Richa Nand, Mr. Jim Dorst, and Mr. Chris Wetzel as non-executive members to the Company’s Board of Directors (“Director”). Effective January 1, 2023, each Director shall receive an annual grant of restricted stock units of $ 50,000 37,500 112,500 Warrants In accordance with ASC 718-20, Compensation – Stock Compensation In March 2023, the Company offered a short-term inducement to the Company’s warrant holders in which the Company will issue one share of the Company’s common stock in exchange for each two warrants returned to the Company to be cancelled. All other terms of the original grants remain the same. A total of 22,393,561 11,196,784 226,929 On October 22, 2021, the Company and Osher amended convertible debt agreements for the maturity date from October 20, 2021 to October 20, 2022 450,000 450,000 197,501 1.00 0 0 49,240 97,939 |
OPERATING LEASES
OPERATING LEASES | 9 Months Ended |
Sep. 30, 2023 | |
Operating Leases | |
OPERATING LEASES | NOTE 9 – OPERATING LEASES On May 27, 2021, the Company entered into a sixty-three month lease for its corporate office at $ 6,134 287,805 287,805 Operating lease right-of-use (“ROU”) assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Generally, the implicit rate of interest in arrangements is not readily determinable and the Company utilizes its incremental borrowing rate in determining the present value of lease payments. The Company’s incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be. The operating lease ROU asset includes any lease payments made and excludes lease incentives. Our variable lease payments primarily consist of maintenance and other operating expenses from our real estate leases. Variable lease payments are excluded from the ROU assets and lease liabilities and are recognized in the period in which the obligation for those payments is incurred. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. We have lease agreements with lease and non-lease components. We have elected to account for these lease and non-lease components as a single lease component. We are also electing not to apply the recognition requirements to short-term leases of twelve months or less and instead will recognize lease payments as expense on a straight-line basis over the lease term. The components of lease expense and supplemental cash flow information related to leases for the period are as follows: In accordance with ASC 842, the components of lease expense were as follows: SCHEDULE OF OPERATING LEASE COST AND SUPPLEMENTAL CASH FLOW INFORMATION 2023 2022 2023 2022 Nine Months ended September 30, Three Months ended September 30, 2023 2022 2023 2022 Operating lease expense $ 53,757 $ 53,757 $ 17,919 $ 17,919 Short term lease cost $ - $ - $ - $ - Total lease expense $ 53,757 $ 53,757 $ 17,919 $ 17,919 In accordance with ASC 842, other information related to leases was as follows: Nine Months ended September 30, 2023 2022 Operating cash flows from operating leases $ 55,941 $ 54,312 Cash paid for amounts included in the measurement of lease liabilities $ 55,941 $ 54,312 Weighted-average remaining lease term—operating leases 2.92 3.92 Weighted-average discount rate—operating leases 10 % 10 % In accordance with ASC 842, maturities of operating lease liabilities as of September 30, 2023 were as follows: SCHEDULE OF MATURITIES OF OPERATING LEASE LIABILITIES Operating Year ending: Lease 2023 (remaining 3 months) $ 18,954 2024 77,142 2025 79,456 2026 54,224 Total undiscounted cash flows $ 229,776 Reconciliation of lease liabilities: Weighted-average remaining lease terms 2.92 Weighted-average discount rate 10 % Present values $ 201,459 Lease liabilities—current 59,061 Lease liabilities—long-term 142,398 Lease liabilities—total $ 201,459 Difference between undiscounted and discounted cash flows $ 28,317 Operating lease cost was $ 17,919 53,757 17,919 53,757 |
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS | 9 Months Ended |
Sep. 30, 2023 | |
Related Party Transactions [Abstract] | |
RELATED PARTY TRANSACTIONS | NOTE 10 – RELATED PARTY TRANSACTIONS Other than as set forth below, and as disclosed in Notes 7 and 8, there have not been any transaction entered into or been a participant in which a related person had or will have a direct or indirect material interest. Employment Agreements Mr. Joyce receives an annual base salary of $ 455,000 50 9 113,750 113,750 345,585 174,960 98,141 31,043 339,317 31,043 On April 1, 2023, the Company entered into an Employment Agreement with Dr. Annette Marleau whereby Dr. Marleau became the Company’s Chief Scientific Officer. Dr. Marleau receives an annual base salary of $ 300,000 3 40 75,000 37,500 151,610 37,500 0 0 Sigyn had no employment agreement with its CTO but still incurred compensation on behalf of the CTO. The Company incurred compensation expense of $ 60,000 60,000 183,288 103,288 53,562 173,678 16,305 |
EARNINGS PER SHARE
EARNINGS PER SHARE | 9 Months Ended |
Sep. 30, 2023 | |
Earnings Per Share [Abstract] | |
EARNINGS PER SHARE | NOTE 11 – EARNINGS PER SHARE FASB ASC Topic 260, Earnings Per Share Basic earnings (loss) per share are computed by dividing net earnings available to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. In periods where losses are reported, the weighted-average number of common stock outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. The following potentially dilutive securities were excluded from the calculation of diluted net loss per share because the effects were anti-dilutive based on the application of the treasury stock method and because the Company incurred net losses during the period: SCHEDULE OF ANTI DILUTIVE SECURITIES 2023 2022 2023 2022 For the Nine Months Ended For the Three Months Ended 2023 2022 2023 2022 Convertible notes payable 21,847,405 9,386,463 21,847,405 9,386,463 Restricted stock units 515,268 - 171,756 - Warrants to purchase shares 2,126,669 11,841,160 2,126,669 11,841,160 Total potentially dilutive shares 24,489,342 21,227,623 24,145,830 21,227,623 The following table sets forth the computation of basic and diluted net income per share: SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET INCOME PER SHARE 2023 2022 2023 2022 Nine Months Ended September 30, Three Months Ended September 30, 2023 2022 2023 2022 Net loss attributable to the common stockholders $ (2,969,886 ) $ (2,070,880 ) $ (905,726 ) $ (726,509 ) Basic weighted average outstanding shares of common stock 42,031,295 37,295,813 44,233,778 37,295,813 Dilutive effect of options and warrants - - - - Diluted weighted average common stock and common stock equivalents 42,031,295 37,295,813 44,233,778 37,295,813 Loss per share: Basic and diluted $ (0.07 ) $ (0.06 ) $ (0.02 ) $ (0.02 ) |
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES | 9 Months Ended |
Sep. 30, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS AND CONTINGENCIES | NOTE 12 – COMMITMENTS AND CONTINGENCIES Legal From time to time, various lawsuits and legal proceedings may arise in the ordinary course of business. However, litigation is subject to inherent uncertainties and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently not aware of any legal proceedings or claims that it believes will have a material adverse effect on its business, financial condition or operating results. Board of Directors Compensation Effective October 10, 2022, the Company’s Board of Directors appointed Ms. Richa Nand, Mr. Jim Dorst, and Mr. Chris Wetzel as non-executive members to the Company’s Board of Directors (“Director”). Each Director shall receive an annual retainer of $ 30,000 50,000 |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 9 Months Ended |
Sep. 30, 2023 | |
Subsequent Events [Abstract] | |
SUBSEQUENT EVENTS | NOTE 13 – SUBSEQUENT EVENTS The Company evaluated all events or transactions that occurred after September 30, 2023 up through the date the financial statements were available to be issued. During this period, the Company did not have any material recognizable subsequent events required to be disclosed as of and for the period ended September 30, 2023, except for the following: In October 2023, the holders of $ 1,322,200 0.18 7,300,342 |
SUMMARY OF SIGNIFICANT ACCOUN_2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 9 Months Ended |
Sep. 30, 2023 | |
Accounting Policies [Abstract] | |
Use of Estimates | Use of Estimates The preparation of these financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the financial statements and the reported amounts of net sales and expenses during the reported periods. Actual results may differ from those estimates and such differences may be material to the financial statements. The more significant estimates and assumptions by management relate to common stock valuation. The current economic environment has increased the degree of uncertainty inherent in these estimates and assumptions. |
Cash | Cash The Company’s cash is held in bank accounts in the United States and is insured by the Federal Deposit Insurance Corporation (FDIC) up to $ 250,000 |
Income Taxes | Income Taxes Income taxes are accounted for under an asset and liability approach. This process involves calculating the temporary and permanent differences between the carrying amounts of the assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The temporary differences result in deferred tax assets and liabilities, which would be recorded on the Balance Sheets in accordance with ASC 740, which established financial accounting and reporting standards for the effect of income taxes. The likelihood that its deferred tax assets will be recovered from future taxable income must be assessed and, to the extent that recovery is not likely, a valuation allowance is established. Changes in the valuation allowance in a period are recorded through the income tax provision in the consolidated Statements of Operations. ASC 740-10 clarifies the accounting for uncertainty in income taxes recognized in an entity’s consolidated financial statements and prescribes a recognition threshold and measurement attributes for financial statement disclosure of tax positions taken or expected to be taken on a tax return. Under ASC 740-10, the impact of an uncertain income tax position on the income tax return must be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Additionally, ASC 740-10 provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. As a result of the implementation of ASC 740-10 and currently, the Company does not have a liability for unrecognized income tax benefits. |
Advertising and Marketing Costs | Advertising and Marketing Costs Advertising expenses are recorded as general and administrative expenses when they are incurred. The Company had $ 51 335 65 446 |
Research and Development | Research and Development All research and development costs are expensed as incurred. The Company incurred research and development expense of $ 215,230 582,232 133,770 516,796 |
Inventories | Inventories In conjunction with the October 19, 2020 Share Exchange Agreement, the Company kept the gem inventory of Reign Resources Corporation. Inventories are stated at the lower of cost or market (net realizable value) on a lot basis each quarter. A lot is determined by the cut, clarity, size, and weight of the sapphires. Inventory consists of sapphire jewels that meet rigorous grading criteria and are of cuts and sizes most commonly used in the jewelry industry. As of September 30, 2023 and December 31, 2022, the Company carried primarily loose sapphire jewels, jewelry for sale on our website, and jewelry held as samples. Samples are used to show potential customers what the jewelry would look like. Promotional items given to customers that are not expected to be returned will be removed from inventory and expensed. There have been no promotional items given to customers as of September 30, 2023. The Company performs its own in-house assessment based on gem guide and the current market price for metals to value its inventory on an annual basis or if circumstances dictate sooner to determine if the estimated fair value is greater or less than cost. In addition, the inventory is reviewed each quarter by the Company against industry prices from gem-guide and if there is a potential impairment, the Company would appraise the inventory. The estimated fair value is subject to significant change due to changes in popularity of cut, perceived grade of the clarity of the sapphires, the number, type and size of inclusions, the availability of other similar quality and size sapphires, and other factors. As a result, the internal assessed value of the sapphires could be significantly lower from the current estimated fair value. Loose sapphire jewels do not degrade in quality over time. |
Property and Equipment | Property and Equipment Property and equipment are carried at cost and are depreciated on a straight-line basis over the estimated useful lives of the assets, generally five years |
Intangible Assets | Intangible Assets Intangible assets consist primarily of website development costs. Our intangible assets are being amortized on a straight-line basis over a period of three years. |
Impairment of Long-lived Assets | Impairment of Long-lived Assets We periodically evaluate whether the carrying value of property, equipment and intangible assets has been impaired when circumstances indicate the carrying value of those assets may not be recoverable. The carrying amount is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. If the carrying value is not recoverable, the impairment loss is measured as the excess of the asset’s carrying value over its fair value. Our impairment analyses require management to apply judgment in estimating future cash flows as well as asset fair values, including forecasting useful lives of the assets, assessing the probability of different outcomes, and selecting the discount rate that reflects the risk inherent in future cash flows. If the carrying value is not recoverable, we assess the fair value of long-lived assets using commonly accepted techniques, and may use more than one method, including, but not limited to, recent third-party comparable sales and discounted cash flow models. If actual results are not consistent with our assumptions and estimates, or our assumptions and estimates change due to new information, we may be exposed to an impairment charge in the future. As of September 30, 2023 and December 31, 2022, the Company had not experienced impairment losses on its long-lived assets. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The provisions of accounting guidance, FASB Topic ASC 825 requires all entities to disclose the fair value of financial instruments, both assets and liabilities recognized and not recognized on the balance sheet, for which it is practicable to estimate fair value, and defines fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties. As of September 30, 2023 and December 31, 2022, the fair value of cash, accounts payable, accrued expenses, and notes payable approximated carrying value due to the short maturity of the instruments, quoted market prices or interest rates which fluctuate with market rates. |
Fair Value Measurements | Fair Value Measurements Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, as follows: ● Level 1 – Quoted prices in active markets for identical assets or liabilities. ● Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. ● Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities The carrying value of financial assets and liabilities recorded at fair value are measured on a recurring or nonrecurring basis. Financial assets and liabilities measured on a non-recurring basis are those that are adjusted to fair value when a significant event occurs. There were no financial assets or liabilities carried and measured on a nonrecurring basis during the reporting periods. Financial assets and liabilities measured on a recurring basis are those that are adjusted to fair value each time a financial statement is prepared. There have been no transfers between levels. |
Debt | Debt The Company issues debt that may have separate warrants, conversion features, or no equity-linked attributes. Embedded Conversion Features The Company evaluates embedded conversion features within convertible debt under ASC 815, Derivatives and Hedging, Debt with Conversion and Other Options Derivative Financial Instruments The Company evaluates all of its financial instruments, including stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported as charges or credits to income. For option-based simple derivative financial instruments, the Company uses the Monte Carlo simulations to value the derivative instruments at inception and subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. There were no derivative financial instruments as of September 30, 2023 and December 31, 2022 and no charges or credits to income for the three and nine months ended September 30, 2023 and 2022. Debt Issue Costs and Debt Discount The Company may record debt issue costs and/or debt discounts in connection with raising funds through the issuance of debt. These costs may be paid in the form of cash or equity (such as warrants). These costs are amortized to interest expense through the maturity of the debt. If a conversion of the underlying debt occurs prior to maturity a proportionate share of the unamortized amounts is immediately expensed. Any unamortized debt issue costs and debt discount are presented net of the related debt on the consolidated balance sheets. Original Issue Discount For certain convertible debt issued, the Company may provide the debt holder with an original issue discount. The original issue discount would be recorded to debt discount, reducing the face amount of the note and is amortized to interest expense through the maturity of the debt. If a conversion of the underlying debt occurs prior to maturity a proportionate share of the unamortized amounts is immediately expensed. Any unamortized original issue discounts are presented net of the related debt on the consolidated balance sheets. If the conversion feature does not qualify for either the derivative treatment or as a beneficial conversion feature, the convertible debt is treated as traditional debt. |
Basic and diluted earnings per share | Basic and diluted earnings per share Basic net loss per share is calculated by dividing the net loss by the weighted-average number of common shares outstanding for the period, without consideration for common stock equivalents. Diluted earnings (loss) per share are computed on the basis of the weighted average number of common shares (including common stock subject to redemption) plus dilutive potential common shares outstanding for the reporting period. In periods where losses are reported, the weighted-average number of common stock outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. Basic and diluted earnings (loss) per share are the same since net losses for all periods presented and including the additional potential common shares would have an anti-dilutive effect. |
Stock Based Compensation | Stock Based Compensation In accordance with ASC No. 718, Compensation – Stock Compensation |
Non-Employee Stock-Based Compensation | Non-Employee Stock-Based Compensation In accordance with ASC 505, Equity Based Payments to Non-Employees, |
Concentrations, Risks, and Uncertainties | Concentrations, Risks, and Uncertainties Business Risk Substantial business risks and uncertainties are inherent to an entity, including the potential risk of business failure. The Company is headquartered and operates in the United States. To date, the Company has generated no revenues from operations. There can be no assurance that the Company will be able to raise additional capital and failure to do so would have a material adverse effect on the Company’s financial position, results of operations and cash flows. Also, the success of the Company’s operations is subject to numerous contingencies, some of which are beyond management’s control. Currently, these contingencies include general economic conditions, price of components, competition, and governmental and political conditions. Interest rate risk Financial assets and liabilities do not have material interest rate risk. Credit risk The Company is exposed to credit risk from its cash in banks. The credit risk on cash in banks is limited because the counterparties are recognized financial institutions. Seasonality The business is not subject to substantial seasonal fluctuations. Major Suppliers Sigyn Therapy is comprised of components that are supplied by various industry vendors. Additionally, the Company is reliant on third-party organizations to conduct clinical development studies that are necessary to advance Sigyn Therapy toward the marketplace. Should the relationship with an industry vendor or third-party clinical development organization be interrupted or discontinued, it is believed that alternate component suppliers and third-party clinical development organizations could be identified to support the continued advancement of Sigyn Therapy. |
Recent Accounting Pronouncements | Recent Accounting Pronouncements There are no recently issued accounting updates that are expected to have a material impact on the Company’s consolidated financial statements. |
PROPERTY AND EQUIPMENT (Tables)
PROPERTY AND EQUIPMENT (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Property, Plant and Equipment [Abstract] | |
SCHEDULE OF PROPERTY AND EQUIPMENT | Property and equipment consisted of the following as of: SCHEDULE OF PROPERTY AND EQUIPMENT Estimated Life September 30, 2023 December 31, 2022 Office equipment 5 years $ 30,410 $ 29,041 Computer equipment 3 years 3,157 3,157 Property and equipment, gross 3 years 3,157 3,157 Accumulated depreciation (15,292 ) (10,146 ) Property and equipment, net $ 16,906 $ 22,052 |
INTANGIBLE ASSETS (Tables)
INTANGIBLE ASSETS (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
SCHEDULE OF INTANGIBLE ASSETS | Intangible assets consisted of the following as of: SCHEDULE OF INTANGIBLE ASSETS Estimated life September 30, 2023 December 31, 2022 Website 3 years $ 10,799 $ 10,799 Accumulated amortization (10,799 ) (8,699 ) Intangible assets, net $ - $ 2,100 |
CONVERTIBLE PROMISSORY DEBENT_2
CONVERTIBLE PROMISSORY DEBENTURES (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Debt Disclosure [Abstract] | |
SCHEDULE OF CONVERTIBLE NOTES PAYABLE | Convertible notes payable consisted of the following: SCHEDULE OF CONVERTIBLE NOTES PAYABLE September 30, 2023 December 31, 2022 January 28, 2020 ($564,138) – 0% interest per annum outstanding principal and interest due August 30, 2024 (“Note 1”) $ 564,138 $ 457,380 January 28, 2020 ($ 564,138 0 August 30, 2024 $ 564,138 $ 457,380 June 23, 2020 ($ 74,621 0 August 30, 2024 74,621 60,500 September 17, 2020 ($ 225,377 0 August 30, 2024 16,714 199,650 42,857 225,377 182,936 March 23, 2022 ($ 259,685 0 August 30, 2024 259,685 220,000 April 28, 2022 ($ 127,979 0 August 30, 2024 127,979 110,000 May 10, 2022 ($ 128,020 0 August 30, 2024 128,020 110,000 June 1, 2022 ($ 63,301 0 August 30, 2024 63,301 55,000 June 22, 2022 ($ 94,314 0 August 30, 2024 94,314 82,500 July 2022 ($ 341,000 0 July 2023 16,500 33,000 324,500 341,000 August 31, 2022 ($ 123,200 0 August 30, 2024 123,200 110,000 September 9, 2022 ($ 92,400 0 August 30, 2024 92,400 82,500 September 20, 2022 ($ 123,200 0 August 30, 2024 123,200 110,000 October 20, 2022 ($ 110,000 0 October 20, 2023 110,000 110,000 November 9, 2022 ($ 92,400 0 August 30, 2024 92,400 82,500 November 14, 2022 ($ 55,000 0 November 14, 2023 55,000 55,000 December 22, 2022 ($ 110,000 0 December 22, 2023 110,000 110,000 During the three and nine months ended September 30, 2023 ($ 1,399,200 0 September 1, 2024 181,500 1,210,000 1,217,700 - Total convertible notes payable 3,785,835 2,279,316 Original issue discount (360,290 ) (74,502 ) Beneficial conversion feature (191,842 ) (175,275 ) Debt discount (285,952 ) (392,883 ) Total convertible notes payable $ 2,947,751 $ 1,636,656 |
SCHEDULE OF PRINCIPAL PAYMENTS DUE ON CONVERTIBLE PROMISSORY DEBENTURES | Principal payments on convertible promissory debentures are due as follows: SCHEDULE OF PRINCIPAL PAYMENTS DUE ON CONVERTIBLE PROMISSORY DEBENTURES Year ending December 31, 2023 (6 months remaining) $ 599,500 2024 $ 3,186,336 Long-Term Debt $ 3,785,836 |
SCHEDULE OF CHANGES IN CONVERTIBLE NOTES | Changes in convertible notes were as follows: SCHEDULE OF CHANGES IN CONVERTIBLE NOTES Note 1 Note 2 Note 3 Note 4 Note 5 Note 6 Note 7 Note 8 Note 9 Note 10 Note 11 Note 12 Note 13 Note 14 Note 15 Note 16 Note 17 Other Totals Convertible notes payable, net, as of December 31, 2021 457,380 60,500 182,936 - - - - - - - - - - - - - - - 700,816 Convertible notes payable issued in 2022 - - - 220,000 110,000 110,000 55,000 82,500 341,000 110,000 82,500 110,000 110,000 82,500 55,000 110,000 - - 1,578,500 Convertible notes payable as of December 31, 2022 $ 457,380 $ 60,500 $ 182,936 $ 220,000 $ 110,000 $ 110,000 $ 55,000 $ 82,500 $ 341,000 $ 110,000 $ 82,500 $ 110,000 $ 110,000 $ 82,500 $ 55,000 $ 110,000 $ - $ - $ 2,279,316 Convertible notes payable issued in 2023 106,758 14,121 42,441 39,685 17,979 18,020 8,301 11,814 - 13,200 9,900 13,200 - 9,900 - - 1,399,200 - 1,704,519 Conversion of debt for common stock - - - - - - - - (16,500 ) - - - - - - - (181,500 ) - (198,000 ) Convertible notes payable as of September 30, 2023 $ 564,138 $ 74,621 $ 225,377 $ 259,685 $ 127,979 $ 128,020 $ 63,301 $ 94,314 $ 324,500 $ 123,200 $ 92,400 $ 123,200 $ 110,000 $ 92,400 $ 55,000 $ 110,000 $ 1,217,700 $ - $ 3,785,835 |
SCHEDULE OF CHANGES IN NOTE DISCOUNTS | Changes in note discounts were as follows: SCHEDULE OF CHANGES IN NOTE DISCOUNTS Note 1 Note 2 Note 3 Note 4 Note 5 Note 6 Note 7 Note 8 Note 9 Note 10 Note 11 Note 12 Note 13 Note 14 Note 15 Note 16 Note 17 Other Totals Note discounts as of December 31, 2021 34,176 4,521 14,917 - - - - - - - - - - - - - - - 53,614 Note discounts issued in conjunction with debt in 2022 - - - 113,418 44,786 44,787 22,794 34,861 140,289 64,104 82,500 110,000 110,000 82,500 55,000 110,000 - - 1,015,039 2022 accretion of note discounts (34,176 ) (4,521 ) (14,917 ) (87,938 ) (30,308 ) (28,836 ) (13,301 ) (18,336 ) (70,720 ) (32,316 ) (39,994 ) (49,874 ) (23,671 ) (12,822 ) (7,726 ) (6,537 ) - 50,000 (425,993 ) Note discounts as of December 31, 2022 $ - $ - $ - $ 25,480 $ 14,478 $ 15,951 $ 9,493 $ 16,525 $ 69,569 $ 31,788 $ 42,506 $ 60,126 $ 86,329 $ 69,678 $ 47,274 $ 103,463 $ - $ 50,000 $ 642,660 Note discounts issued in conjunction with debt in 2023 106,758 14,121 42,441 39,685 17,979 18,020 8,301 11,814 - 13,200 9,900 13,200 - 9,900 - - 1,346,539 - 1,651,858 2023 accretion of note discounts (4,680 ) (619 ) (1,860 ) (27,220 ) (15,267 ) (16,741 ) (9,857 ) (17,043 ) (69,569 ) (32,367 ) (42,939 ) (60,705 ) (79,756 ) (60,250 ) (39,877 ) (79,754 ) (847,930 ) (50,000 ) (1,456,434 ) Note discounts as of September 30, 2023 $ 102,078 $ 13,502 $ 40,581 $ 37,945 $ 17,190 $ 17,230 $ 7,937 $ 11,296 $ - $ 12,621 $ 9,467 $ 12,621 $ 6,573 $ 19,328 $ 7,397 $ 23,709 $ 498,609 $ - $ 838,084 Convertible notes payable, net, as of December 31, 2021 $ 423,204 $ 55,979 $ 168,019 $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ 647,202 Convertible notes payable, net, as of December 31, 2022 $ 457,380 $ 60,500 $ 182,936 $ 194,520 $ 95,522 $ 94,049 $ 45,507 $ 65,975 $ 271,431 $ 78,212 $ 39,994 $ 49,874 $ 23,671 $ 12,822 $ 7,726 $ 6,537 $ - $ (50,000 ) $ 1,636,656 Convertible notes payable, net, as of September 30, 2023 $ 462,060 $ 61,119 $ 184,796 $ 221,740 $ 110,789 $ 110,790 $ 55,364 $ 83,018 $ 324,500 $ 110,579 $ 82,933 $ 110,579 $ 103,427 $ 73,072 $ 47,603 $ 86,291 $ 719,091 $ - $ 2,947,751 2021 Effective interest rate 11 % 11 % 12 % - - - - - - - - - - - - - - - - 2022 Effective interest rate 7 % 7 % 8 % 40 % 28 % 26 % 24 % 22 % 21 % 29 % 48 % 45 % 22 % 16 % 14 % 6 % - - 19 % 2023 Effective interest rate 1 % 1 % 1 % 10 % 12 % 13 % 16 % 18 % 21 % 26 % 46 % 49 % 73 % 65 % 73 % 73 % 70 % - 38 % |
OPERATING LEASES (Tables)
OPERATING LEASES (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Operating Leases | |
SCHEDULE OF OPERATING LEASE COST AND SUPPLEMENTAL CASH FLOW INFORMATION | In accordance with ASC 842, the components of lease expense were as follows: SCHEDULE OF OPERATING LEASE COST AND SUPPLEMENTAL CASH FLOW INFORMATION 2023 2022 2023 2022 Nine Months ended September 30, Three Months ended September 30, 2023 2022 2023 2022 Operating lease expense $ 53,757 $ 53,757 $ 17,919 $ 17,919 Short term lease cost $ - $ - $ - $ - Total lease expense $ 53,757 $ 53,757 $ 17,919 $ 17,919 In accordance with ASC 842, other information related to leases was as follows: Nine Months ended September 30, 2023 2022 Operating cash flows from operating leases $ 55,941 $ 54,312 Cash paid for amounts included in the measurement of lease liabilities $ 55,941 $ 54,312 Weighted-average remaining lease term—operating leases 2.92 3.92 Weighted-average discount rate—operating leases 10 % 10 % |
SCHEDULE OF MATURITIES OF OPERATING LEASE LIABILITIES | In accordance with ASC 842, maturities of operating lease liabilities as of September 30, 2023 were as follows: SCHEDULE OF MATURITIES OF OPERATING LEASE LIABILITIES Operating Year ending: Lease 2023 (remaining 3 months) $ 18,954 2024 77,142 2025 79,456 2026 54,224 Total undiscounted cash flows $ 229,776 Reconciliation of lease liabilities: Weighted-average remaining lease terms 2.92 Weighted-average discount rate 10 % Present values $ 201,459 Lease liabilities—current 59,061 Lease liabilities—long-term 142,398 Lease liabilities—total $ 201,459 Difference between undiscounted and discounted cash flows $ 28,317 |
EARNINGS PER SHARE (Tables)
EARNINGS PER SHARE (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Earnings Per Share [Abstract] | |
SCHEDULE OF ANTI DILUTIVE SECURITIES | The following potentially dilutive securities were excluded from the calculation of diluted net loss per share because the effects were anti-dilutive based on the application of the treasury stock method and because the Company incurred net losses during the period: SCHEDULE OF ANTI DILUTIVE SECURITIES 2023 2022 2023 2022 For the Nine Months Ended For the Three Months Ended 2023 2022 2023 2022 Convertible notes payable 21,847,405 9,386,463 21,847,405 9,386,463 Restricted stock units 515,268 - 171,756 - Warrants to purchase shares 2,126,669 11,841,160 2,126,669 11,841,160 Total potentially dilutive shares 24,489,342 21,227,623 24,145,830 21,227,623 |
SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET INCOME PER SHARE | The following table sets forth the computation of basic and diluted net income per share: SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET INCOME PER SHARE 2023 2022 2023 2022 Nine Months Ended September 30, Three Months Ended September 30, 2023 2022 2023 2022 Net loss attributable to the common stockholders $ (2,969,886 ) $ (2,070,880 ) $ (905,726 ) $ (726,509 ) Basic weighted average outstanding shares of common stock 42,031,295 37,295,813 44,233,778 37,295,813 Dilutive effect of options and warrants - - - - Diluted weighted average common stock and common stock equivalents 42,031,295 37,295,813 44,233,778 37,295,813 Loss per share: Basic and diluted $ (0.07 ) $ (0.06 ) $ (0.02 ) $ (0.02 ) |
ORGANIZATION AND PRINCIPAL AC_2
ORGANIZATION AND PRINCIPAL ACTIVITIES (Details Narrative) - USD ($) | 9 Months Ended | ||
Oct. 19, 2020 | Sep. 30, 2023 | Sep. 30, 2022 | |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||
Converted liabilities | $ 198,000 | ||
Share Exchange Agreement [Member] | |||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||
Percentage of common stock outstanding | 75% | ||
Converted liabilities | $ 3,429,516 | ||
Conversion shares | 7,907,351 | ||
Share Exchange Agreement [Member] | Sigyn Stockholders [Member] | |||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||
Percentage of acquisition ownership interest | 75% | ||
Share Exchange Agreement [Member] | Issued and Outstanding Shares [Member] | |||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||
Percentage of acquisition ownership interest | 100% |
BASIS OF PRESENTATION (Details
BASIS OF PRESENTATION (Details Narrative) - USD ($) | 3 Months Ended | 9 Months Ended | |||||||
Sep. 30, 2023 | Jun. 30, 2023 | Mar. 31, 2023 | Sep. 30, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | Dec. 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||||
Accumulated deficit | $ 10,165,462 | $ 10,165,462 | $ 7,195,576 | ||||||
Working capital | 3,651,625 | 3,651,625 | |||||||
Net loss | $ 905,726 | $ 723,124 | $ 1,341,036 | $ 726,509 | $ 666,325 | $ 678,046 | 2,969,886 | $ 2,070,880 | |
Net cash provided by used in operating activities | $ 1,255,316 | $ 1,378,475 |
SUMMARY OF SIGNIFICANT ACCOUN_3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Accounting Policies [Abstract] | ||||
Cash FDIC insured amount | $ 250,000 | $ 250,000 | ||
Advertising expenses | 51 | $ 65 | 335 | $ 446 |
Research and development expense | $ 215,230 | $ 133,770 | $ 582,232 | $ 516,796 |
Property and equipment, useful life | 5 years | 5 years |
SCHEDULE OF PROPERTY AND EQUIPM
SCHEDULE OF PROPERTY AND EQUIPMENT (Details) - USD ($) | Sep. 30, 2023 | Dec. 31, 2022 |
Property, Plant and Equipment [Line Items] | ||
Estimated useful life | 5 years | |
Accumulated depreciation | $ (15,292) | $ (10,146) |
Property and equipment, net | 16,906 | 22,052 |
Office Equipment [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | $ 30,410 | 29,041 |
Estimated useful life | 5 years | |
Computer Equipment [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | $ 3,157 | $ 3,157 |
Estimated useful life | 3 years |
PROPERTY AND EQUIPMENT (Details
PROPERTY AND EQUIPMENT (Details Narrative) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Property, Plant and Equipment [Abstract] | ||||
Depreciation expense | $ 1,716 | $ 1,716 | $ 5,146 | $ 5,139 |
SCHEDULE OF INTANGIBLE ASSETS (
SCHEDULE OF INTANGIBLE ASSETS (Details) - USD ($) | Sep. 30, 2023 | Dec. 31, 2022 |
Goodwill and Intangible Assets Disclosure [Abstract] | ||
Website | $ 10,799 | $ 10,799 |
Intangible assets amortization period | 3 years | |
Accumulated amortization | $ (10,799) | (8,699) |
Intangible assets, net | $ 2,100 |
INTANGIBLE ASSETS (Details Narr
INTANGIBLE ASSETS (Details Narrative) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | ||||
Amortization expense | $ 300 | $ 900 | $ 2,100 | $ 2,700 |
SCHEDULE OF CONVERTIBLE NOTES P
SCHEDULE OF CONVERTIBLE NOTES PAYABLE (Details) - USD ($) | Sep. 30, 2023 | Dec. 31, 2022 | Dec. 22, 2022 | Nov. 14, 2022 | Nov. 09, 2022 | Oct. 20, 2022 | Sep. 20, 2022 | Sep. 09, 2022 | Aug. 31, 2022 | Jul. 31, 2022 | Jun. 22, 2022 | Jun. 01, 2022 | May 10, 2022 | Apr. 28, 2022 | Mar. 23, 2022 | Dec. 31, 2021 | Sep. 17, 2020 | Jun. 23, 2020 | Jan. 28, 2020 |
Short-Term Debt [Line Items] | |||||||||||||||||||
Convertible notes payable | $ 3,785,835 | $ 2,279,316 | $ 700,816 | ||||||||||||||||
Original issue discount | (360,290) | (74,502) | |||||||||||||||||
Beneficial conversion feature | (191,842) | (175,275) | |||||||||||||||||
Debt discount | (285,952) | (392,883) | |||||||||||||||||
Total convertible notes payable | 2,947,751 | 1,636,656 | |||||||||||||||||
Convertible Promissory Note One [Member] | |||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||
Convertible notes payable | 564,138 | 457,380 | 457,380 | $ 564,138 | |||||||||||||||
Convertible Promissory Note Two [Member] | |||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||
Convertible notes payable | 74,621 | 60,500 | 60,500 | $ 74,621 | |||||||||||||||
Convertible Promissory Note Three [Member] | |||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||
Convertible notes payable | 225,377 | 182,936 | 182,936 | $ 225,377 | |||||||||||||||
Convertible Promissory Note Four [Member] | |||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||
Convertible notes payable | 259,685 | 220,000 | $ 259,685 | ||||||||||||||||
Convertible Promissory Note Five [Member] | |||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||
Convertible notes payable | 127,979 | 110,000 | $ 127,979 | ||||||||||||||||
Convertible Promissory Note Six [Member] | |||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||
Convertible notes payable | 128,020 | 110,000 | $ 128,020 | ||||||||||||||||
Convertible Promissory Note Seven [Member] | |||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||
Convertible notes payable | 63,301 | 55,000 | $ 63,301 | ||||||||||||||||
Convertible Promissory Note Eight [Member] | |||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||
Convertible notes payable | 94,314 | 82,500 | $ 94,314 | ||||||||||||||||
Convertible Promissory Note Nine [Member] | |||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||
Convertible notes payable | 324,500 | 341,000 | $ 341,000 | ||||||||||||||||
Convertible Promissory Note Ten [Member] | |||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||
Convertible notes payable | 123,200 | 110,000 | $ 123,200 | ||||||||||||||||
Convertible Promissory Note Eleven [Member] | |||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||
Convertible notes payable | 92,400 | 82,500 | $ 92,400 | ||||||||||||||||
Convertible Promissory Note Twelve [Member] | |||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||
Convertible notes payable | 123,200 | 110,000 | $ 123,200 | ||||||||||||||||
Convertible Promissory Note Thirteen [Member] | |||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||
Convertible notes payable | 110,000 | 110,000 | $ 110,000 | ||||||||||||||||
Convertible Promissory Note Fourteen [Member] | |||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||
Convertible notes payable | 92,400 | 82,500 | $ 92,400 | ||||||||||||||||
Convertible Promissory Note Fifteen [Member] | |||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||
Convertible notes payable | 55,000 | 55,000 | $ 55,000 | ||||||||||||||||
Convertible Promissory Note Sixteen [Member] | |||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||
Convertible notes payable | 110,000 | 110,000 | $ 110,000 | ||||||||||||||||
Convertible Promissory Note Seventeen [Member] | |||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||
Convertible notes payable | $ 1,217,700 |
SCHEDULE OF CONVERTIBLE NOTES_2
SCHEDULE OF CONVERTIBLE NOTES PAYABLE (Details) (Parenthetical) - USD ($) | 1 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | |||||||||||||||||||||
Sep. 30, 2023 | Jun. 02, 2023 | Dec. 22, 2022 | Dec. 22, 2022 | Nov. 14, 2022 | Nov. 09, 2022 | Oct. 20, 2022 | Sep. 20, 2022 | Sep. 09, 2022 | Aug. 31, 2022 | Jul. 31, 2022 | Jun. 22, 2022 | Jun. 01, 2022 | May 10, 2022 | Apr. 28, 2022 | Mar. 23, 2022 | Oct. 28, 2021 | Sep. 17, 2020 | Jun. 23, 2020 | Jan. 28, 2020 | Aug. 31, 2022 | Sep. 30, 2023 | Sep. 30, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Short-Term Debt [Line Items] | |||||||||||||||||||||||||
Convertible notes payable | $ 3,785,835 | $ 3,785,835 | $ 3,785,835 | $ 2,279,316 | $ 700,816 | ||||||||||||||||||||
Convertible notes payable | 1,704,519 | 1,578,500 | |||||||||||||||||||||||
Convertible Promissory Note One [Member] | |||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||
Convertible notes payable | 564,138 | $ 564,138 | 564,138 | 564,138 | 457,380 | 457,380 | |||||||||||||||||||
Debt instrument interest rate | 0% | ||||||||||||||||||||||||
Debt instrument maturity date | Aug. 30, 2024 | ||||||||||||||||||||||||
Convertible notes payable | 106,758 | ||||||||||||||||||||||||
Convertible Promissory Note Two [Member] | |||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||
Convertible notes payable | 74,621 | $ 74,621 | 74,621 | 74,621 | 60,500 | 60,500 | |||||||||||||||||||
Debt instrument interest rate | 0% | ||||||||||||||||||||||||
Debt instrument maturity date | Aug. 30, 2024 | ||||||||||||||||||||||||
Convertible notes payable | 14,121 | ||||||||||||||||||||||||
Convertible Promissory Note Three [Member] | |||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||
Convertible notes payable | 225,377 | $ 225,377 | 225,377 | 225,377 | 182,936 | 182,936 | |||||||||||||||||||
Debt instrument interest rate | 0% | ||||||||||||||||||||||||
Debt instrument maturity date | Aug. 30, 2024 | ||||||||||||||||||||||||
Convertible notes payable | 42,441 | ||||||||||||||||||||||||
Convertible Promissory Note Three [Member] | Osher Capital Partners LLC [Member] | |||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||
Aggregate principal amount of debt | $ 16,714 | ||||||||||||||||||||||||
Debt conversion debt | $ 199,650 | ||||||||||||||||||||||||
Debt conversion converted instrument shares | 42,857 | ||||||||||||||||||||||||
Convertible Promissory Note Four [Member] | |||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||
Convertible notes payable | 259,685 | $ 259,685 | 259,685 | 259,685 | 220,000 | ||||||||||||||||||||
Debt instrument interest rate | 0% | ||||||||||||||||||||||||
Debt instrument maturity date | Aug. 30, 2024 | ||||||||||||||||||||||||
Convertible notes payable | 39,685 | 220,000 | |||||||||||||||||||||||
Convertible Promissory Note Four [Member] | Osher Capital Partners LLC [Member] | |||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||
Debt instrument maturity date | Mar. 23, 2023 | ||||||||||||||||||||||||
Aggregate principal amount of debt | $ 110,000 | ||||||||||||||||||||||||
Convertible Promissory Note Five [Member] | |||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||
Convertible notes payable | 127,979 | $ 127,979 | 127,979 | 127,979 | 110,000 | ||||||||||||||||||||
Debt instrument interest rate | 0% | ||||||||||||||||||||||||
Debt instrument maturity date | Aug. 30, 2024 | ||||||||||||||||||||||||
Convertible notes payable | 17,979 | 110,000 | |||||||||||||||||||||||
Convertible Promissory Note Five [Member] | Osher Capital Partners LLC [Member] | |||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||
Debt instrument maturity date | Apr. 28, 2023 | ||||||||||||||||||||||||
Aggregate principal amount of debt | $ 110,000 | ||||||||||||||||||||||||
Convertible Promissory Note Six [Member] | |||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||
Convertible notes payable | 128,020 | $ 128,020 | 128,020 | 128,020 | 110,000 | ||||||||||||||||||||
Debt instrument interest rate | 0% | ||||||||||||||||||||||||
Debt instrument maturity date | Aug. 30, 2024 | ||||||||||||||||||||||||
Convertible notes payable | 18,020 | 110,000 | |||||||||||||||||||||||
Convertible Promissory Note Seven [Member] | |||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||
Convertible notes payable | 63,301 | $ 63,301 | 63,301 | 63,301 | 55,000 | ||||||||||||||||||||
Debt instrument interest rate | 0% | ||||||||||||||||||||||||
Debt instrument maturity date | Aug. 30, 2024 | ||||||||||||||||||||||||
Convertible notes payable | 8,301 | 55,000 | |||||||||||||||||||||||
Convertible Promissory Note Seven [Member] | Osher Capital Partners LLC [Member] | |||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||
Debt instrument maturity date | Jun. 01, 2023 | ||||||||||||||||||||||||
Aggregate principal amount of debt | $ 55,000 | ||||||||||||||||||||||||
Convertible Promissory Note Eight [Member] | |||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||
Convertible notes payable | 94,314 | $ 94,314 | 94,314 | 94,314 | 82,500 | ||||||||||||||||||||
Debt instrument interest rate | 0% | ||||||||||||||||||||||||
Debt instrument maturity date | Aug. 30, 2024 | ||||||||||||||||||||||||
Convertible notes payable | 11,814 | 82,500 | |||||||||||||||||||||||
Convertible Promissory Note Eight [Member] | Osher Capital Partners LLC [Member] | |||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||
Debt instrument maturity date | Jun. 22, 2023 | ||||||||||||||||||||||||
Aggregate principal amount of debt | $ 82,500 | ||||||||||||||||||||||||
Convertible Promissory Note Nine [Member] | |||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||
Convertible notes payable | 324,500 | $ 341,000 | 324,500 | 324,500 | 341,000 | ||||||||||||||||||||
Debt instrument interest rate | 0% | ||||||||||||||||||||||||
Aggregate principal amount of debt | $ 16,500 | ||||||||||||||||||||||||
Debt conversion converted instrument shares | 33,000 | ||||||||||||||||||||||||
Debt instrument maturity period | July 2023 | ||||||||||||||||||||||||
Convertible notes payable | 341,000 | ||||||||||||||||||||||||
Convertible Promissory Note Nine [Member] | Osher Capital Partners LLC [Member] | |||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||
Aggregate principal amount of debt | $ 16,500 | $ 341,000 | |||||||||||||||||||||||
Convertible Promissory Note Ten [Member] | |||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||
Convertible notes payable | 123,200 | $ 123,200 | $ 123,200 | 123,200 | 123,200 | 110,000 | |||||||||||||||||||
Debt instrument interest rate | 0% | 0% | |||||||||||||||||||||||
Debt instrument maturity date | Aug. 30, 2024 | ||||||||||||||||||||||||
Convertible notes payable | 13,200 | 110,000 | |||||||||||||||||||||||
Convertible Promissory Note Ten [Member] | Osher Capital Partners LLC [Member] | |||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||
Debt instrument maturity date | Aug. 31, 2023 | ||||||||||||||||||||||||
Aggregate principal amount of debt | $ 110,000 | $ 110,000 | |||||||||||||||||||||||
Convertible Promissory Note Eleven [Member] | |||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||
Convertible notes payable | 92,400 | $ 92,400 | 92,400 | 92,400 | 82,500 | ||||||||||||||||||||
Debt instrument maturity date | Aug. 30, 2024 | ||||||||||||||||||||||||
Convertible notes payable | 9,900 | 82,500 | |||||||||||||||||||||||
Convertible Promissory Note Twelve [Member] | |||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||
Convertible notes payable | 123,200 | $ 123,200 | 123,200 | 123,200 | 110,000 | ||||||||||||||||||||
Debt instrument interest rate | 0% | ||||||||||||||||||||||||
Debt instrument maturity date | Aug. 30, 2024 | ||||||||||||||||||||||||
Convertible notes payable | 13,200 | 110,000 | |||||||||||||||||||||||
Convertible Promissory Note Twelve [Member] | Osher Capital Partners LLC [Member] | |||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||
Debt instrument maturity date | Sep. 20, 2023 | ||||||||||||||||||||||||
Aggregate principal amount of debt | $ 110,000 | ||||||||||||||||||||||||
Convertible Promissory Note Thirteen [Member] | |||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||
Convertible notes payable | 110,000 | $ 110,000 | 110,000 | 110,000 | 110,000 | ||||||||||||||||||||
Debt instrument interest rate | 0% | ||||||||||||||||||||||||
Debt instrument maturity date | Oct. 20, 2023 | ||||||||||||||||||||||||
Convertible notes payable | 110,000 | ||||||||||||||||||||||||
Convertible Promissory Note Thirteen [Member] | Osher Capital Partners LLC [Member] | |||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||
Debt instrument maturity date | Oct. 20, 2023 | ||||||||||||||||||||||||
Aggregate principal amount of debt | $ 110,000 | ||||||||||||||||||||||||
Convertible Promissory Note Fourteen [Member] | |||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||
Convertible notes payable | 92,400 | $ 92,400 | 92,400 | 92,400 | 82,500 | ||||||||||||||||||||
Debt instrument interest rate | 0% | ||||||||||||||||||||||||
Debt instrument maturity date | Aug. 30, 2024 | ||||||||||||||||||||||||
Convertible notes payable | 9,900 | 82,500 | |||||||||||||||||||||||
Convertible Promissory Note Fourteen [Member] | Osher Capital Partners LLC [Member] | |||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||
Debt instrument maturity date | Nov. 09, 2023 | ||||||||||||||||||||||||
Aggregate principal amount of debt | $ 82,500 | ||||||||||||||||||||||||
Convertible Promissory Note Fifteen [Member] | |||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||
Convertible notes payable | 55,000 | $ 55,000 | 55,000 | 55,000 | 55,000 | ||||||||||||||||||||
Debt instrument interest rate | 0% | ||||||||||||||||||||||||
Debt instrument maturity date | Nov. 14, 2023 | ||||||||||||||||||||||||
Convertible notes payable | 55,000 | ||||||||||||||||||||||||
Convertible Promissory Note Fifteen [Member] | Osher Capital Partners LLC [Member] | |||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||
Debt instrument maturity date | Nov. 14, 2023 | ||||||||||||||||||||||||
Aggregate principal amount of debt | $ 55,000 | ||||||||||||||||||||||||
Convertible Promissory Note Sixteen [Member] | |||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||
Convertible notes payable | 110,000 | $ 110,000 | $ 110,000 | 110,000 | 110,000 | 110,000 | |||||||||||||||||||
Debt instrument interest rate | 0% | 0% | |||||||||||||||||||||||
Debt instrument maturity date | Dec. 22, 2023 | ||||||||||||||||||||||||
Convertible notes payable | 110,000 | ||||||||||||||||||||||||
Convertible Promissory Note Sixteen [Member] | Osher Capital Partners LLC [Member] | |||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||
Debt instrument maturity date | Dec. 22, 2023 | ||||||||||||||||||||||||
Aggregate principal amount of debt | $ 110,000 | $ 110,000 | |||||||||||||||||||||||
Convertible Promissory Note Seventeen [Member] | |||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||
Convertible notes payable | $ 1,217,700 | $ 1,217,700 | $ 1,217,700 | ||||||||||||||||||||||
Debt instrument interest rate | 0% | 0% | 0% | ||||||||||||||||||||||
Debt instrument maturity date | Sep. 01, 2024 | ||||||||||||||||||||||||
Aggregate principal amount of debt | $ 181,500 | ||||||||||||||||||||||||
Debt conversion converted instrument shares | 1,210,000 | ||||||||||||||||||||||||
Convertible notes payable | $ 1,399,200 | $ 1,399,200 | |||||||||||||||||||||||
Convertible Promissory Note Seventeen [Member] | Osher Capital Partners LLC [Member] | |||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||
Debt instrument maturity date | Sep. 01, 2024 | ||||||||||||||||||||||||
Aggregate principal amount of debt | $ 1,399,200 | $ 181,500 | $ 1,399,200 | $ 1,399,200 | |||||||||||||||||||||
Debt instrument maturity period | January 2024 through September 1, 2024 based on $1.00 for each $0.90909 paid by the previous noteholder |
SCHEDULE OF PRINCIPAL PAYMENTS
SCHEDULE OF PRINCIPAL PAYMENTS DUE ON CONVERTIBLE PROMISSORY DEBENTURES (Details) | Sep. 30, 2023 USD ($) |
Debt Disclosure [Abstract] | |
2023 (6 months remaining) | $ 599,500 |
2024 | 3,186,336 |
Long-Term Debt | $ 3,785,836 |
SCHEDULE OF CHANGES IN CONVERTI
SCHEDULE OF CHANGES IN CONVERTIBLE NOTES (Details) - USD ($) | 3 Months Ended | 9 Months Ended | 12 Months Ended |
Sep. 30, 2023 | Sep. 30, 2023 | Dec. 31, 2022 | |
Short-Term Debt [Line Items] | |||
Convertible notes payable as of December 31, 2022 | $ 2,279,316 | $ 700,816 | |
Convertible notes payable issued in 2023 | 1,704,519 | 1,578,500 | |
Conversion of debt for common stock | (198,000) | ||
Convertible notes payable as of September 30, 2023 | $ 3,785,835 | 3,785,835 | 2,279,316 |
Convertible Promissory Note One [Member] | |||
Short-Term Debt [Line Items] | |||
Convertible notes payable as of December 31, 2022 | 457,380 | 457,380 | |
Convertible notes payable issued in 2023 | 106,758 | ||
Conversion of debt for common stock | |||
Convertible notes payable as of September 30, 2023 | 564,138 | 564,138 | 457,380 |
Convertible Promissory Note Two [Member] | |||
Short-Term Debt [Line Items] | |||
Convertible notes payable as of December 31, 2022 | 60,500 | 60,500 | |
Convertible notes payable issued in 2023 | 14,121 | ||
Conversion of debt for common stock | |||
Convertible notes payable as of September 30, 2023 | 74,621 | 74,621 | 60,500 |
Convertible Promissory Note Three [Member] | |||
Short-Term Debt [Line Items] | |||
Convertible notes payable as of December 31, 2022 | 182,936 | 182,936 | |
Convertible notes payable issued in 2023 | 42,441 | ||
Conversion of debt for common stock | |||
Convertible notes payable as of September 30, 2023 | 225,377 | 225,377 | 182,936 |
Convertible Promissory Note Four [Member] | |||
Short-Term Debt [Line Items] | |||
Convertible notes payable as of December 31, 2022 | 220,000 | ||
Convertible notes payable issued in 2023 | 39,685 | 220,000 | |
Conversion of debt for common stock | |||
Convertible notes payable as of September 30, 2023 | 259,685 | 259,685 | 220,000 |
Convertible Promissory Note Five [Member] | |||
Short-Term Debt [Line Items] | |||
Convertible notes payable as of December 31, 2022 | 110,000 | ||
Convertible notes payable issued in 2023 | 17,979 | 110,000 | |
Conversion of debt for common stock | |||
Convertible notes payable as of September 30, 2023 | 127,979 | 127,979 | 110,000 |
Convertible Promissory Note Six [Member] | |||
Short-Term Debt [Line Items] | |||
Convertible notes payable as of December 31, 2022 | 110,000 | ||
Convertible notes payable issued in 2023 | 18,020 | 110,000 | |
Conversion of debt for common stock | |||
Convertible notes payable as of September 30, 2023 | 128,020 | 128,020 | 110,000 |
Convertible Promissory Note Seven [Member] | |||
Short-Term Debt [Line Items] | |||
Convertible notes payable as of December 31, 2022 | 55,000 | ||
Convertible notes payable issued in 2023 | 8,301 | 55,000 | |
Conversion of debt for common stock | |||
Convertible notes payable as of September 30, 2023 | 63,301 | 63,301 | 55,000 |
Convertible Promissory Note Eight [Member] | |||
Short-Term Debt [Line Items] | |||
Convertible notes payable as of December 31, 2022 | 82,500 | ||
Convertible notes payable issued in 2023 | 11,814 | 82,500 | |
Conversion of debt for common stock | |||
Convertible notes payable as of September 30, 2023 | 94,314 | 94,314 | 82,500 |
Convertible Promissory Note Nine [Member] | |||
Short-Term Debt [Line Items] | |||
Convertible notes payable as of December 31, 2022 | 341,000 | ||
Convertible notes payable issued in 2023 | 341,000 | ||
Conversion of debt for common stock | (16,500) | ||
Convertible notes payable as of September 30, 2023 | 324,500 | 324,500 | 341,000 |
Convertible Promissory Note Ten [Member] | |||
Short-Term Debt [Line Items] | |||
Convertible notes payable as of December 31, 2022 | 110,000 | ||
Convertible notes payable issued in 2023 | 13,200 | 110,000 | |
Conversion of debt for common stock | |||
Convertible notes payable as of September 30, 2023 | 123,200 | 123,200 | 110,000 |
Convertible Promissory Note Eleven [Member] | |||
Short-Term Debt [Line Items] | |||
Convertible notes payable as of December 31, 2022 | 82,500 | ||
Convertible notes payable issued in 2023 | 9,900 | 82,500 | |
Conversion of debt for common stock | |||
Convertible notes payable as of September 30, 2023 | 92,400 | 92,400 | 82,500 |
Convertible Promissory Note Twelve [Member] | |||
Short-Term Debt [Line Items] | |||
Convertible notes payable as of December 31, 2022 | 110,000 | ||
Convertible notes payable issued in 2023 | 13,200 | 110,000 | |
Conversion of debt for common stock | |||
Convertible notes payable as of September 30, 2023 | 123,200 | 123,200 | 110,000 |
Convertible Promissory Note Thirteen [Member] | |||
Short-Term Debt [Line Items] | |||
Convertible notes payable as of December 31, 2022 | 110,000 | ||
Convertible notes payable issued in 2023 | 110,000 | ||
Conversion of debt for common stock | |||
Convertible notes payable as of September 30, 2023 | 110,000 | 110,000 | 110,000 |
Convertible Promissory Note Fourteen [Member] | |||
Short-Term Debt [Line Items] | |||
Convertible notes payable as of December 31, 2022 | 82,500 | ||
Convertible notes payable issued in 2023 | 9,900 | 82,500 | |
Conversion of debt for common stock | |||
Convertible notes payable as of September 30, 2023 | 92,400 | 92,400 | 82,500 |
Convertible Promissory Note Fifteen [Member] | |||
Short-Term Debt [Line Items] | |||
Convertible notes payable as of December 31, 2022 | 55,000 | ||
Convertible notes payable issued in 2023 | 55,000 | ||
Conversion of debt for common stock | |||
Convertible notes payable as of September 30, 2023 | 55,000 | 55,000 | 55,000 |
Convertible Promissory Note Sixteen [Member] | |||
Short-Term Debt [Line Items] | |||
Convertible notes payable as of December 31, 2022 | 110,000 | ||
Convertible notes payable issued in 2023 | 110,000 | ||
Conversion of debt for common stock | |||
Convertible notes payable as of September 30, 2023 | 110,000 | 110,000 | 110,000 |
Convertible Promissory Note Seventeen [Member] | |||
Short-Term Debt [Line Items] | |||
Convertible notes payable as of December 31, 2022 | |||
Convertible notes payable issued in 2023 | 1,399,200 | 1,399,200 | |
Conversion of debt for common stock | (181,500) | ||
Convertible notes payable as of September 30, 2023 | 1,217,700 | 1,217,700 | |
Convertible Promissory Note Other [Member] | |||
Short-Term Debt [Line Items] | |||
Convertible notes payable as of December 31, 2022 | |||
Convertible notes payable issued in 2023 | |||
Conversion of debt for common stock | |||
Convertible notes payable as of September 30, 2023 |
SCHEDULE OF CHANGES IN NOTE DIS
SCHEDULE OF CHANGES IN NOTE DISCOUNTS (Details) - USD ($) | 9 Months Ended | 12 Months Ended | ||
Sep. 30, 2023 | Dec. 31, 2022 | Dec. 31, 2023 | Dec. 31, 2021 | |
Short-Term Debt [Line Items] | ||||
Note discounts as of December 31, 2022 | $ 642,660 | $ 53,614 | ||
Note discounts issued in conjunction with debt in 2022 | 1,015,039 | |||
2023 accretion of note discounts | (1,456,434) | (425,993) | ||
Note discounts issued in conjunction with debt in 2023 | 1,651,858 | |||
Note discounts as of September 30, 2023 | 838,084 | 642,660 | ||
Convertible notes payable, net, as of September 30, 2023 | 2,947,751 | $ 1,636,656 | $ 647,202 | |
Effective interest rate | 19% | 38% | ||
Convertible Promissory Note One [Member] | ||||
Short-Term Debt [Line Items] | ||||
Note discounts as of December 31, 2022 | $ 34,176 | |||
Note discounts issued in conjunction with debt in 2022 | ||||
2023 accretion of note discounts | (4,680) | (34,176) | ||
Note discounts issued in conjunction with debt in 2023 | 106,758 | |||
Note discounts as of September 30, 2023 | 102,078 | |||
Convertible notes payable, net, as of September 30, 2023 | 462,060 | $ 457,380 | $ 423,204 | |
Effective interest rate | 7% | 1% | 11% | |
Convertible Promissory Note Two [Member] | ||||
Short-Term Debt [Line Items] | ||||
Note discounts as of December 31, 2022 | $ 4,521 | |||
Note discounts issued in conjunction with debt in 2022 | ||||
2023 accretion of note discounts | (619) | (4,521) | ||
Note discounts issued in conjunction with debt in 2023 | 14,121 | |||
Note discounts as of September 30, 2023 | 13,502 | |||
Convertible notes payable, net, as of September 30, 2023 | 61,119 | $ 60,500 | $ 55,979 | |
Effective interest rate | 7% | 1% | 11% | |
Convertible Promissory Note Three [Member] | ||||
Short-Term Debt [Line Items] | ||||
Note discounts as of December 31, 2022 | $ 14,917 | |||
Note discounts issued in conjunction with debt in 2022 | ||||
2023 accretion of note discounts | (1,860) | (14,917) | ||
Note discounts issued in conjunction with debt in 2023 | 42,441 | |||
Note discounts as of September 30, 2023 | 40,581 | |||
Convertible notes payable, net, as of September 30, 2023 | 184,796 | $ 182,936 | $ 168,019 | |
Effective interest rate | 8% | 1% | 12% | |
Convertible Promissory Note Four [Member] | ||||
Short-Term Debt [Line Items] | ||||
Note discounts as of December 31, 2022 | 25,480 | |||
Note discounts issued in conjunction with debt in 2022 | 113,418 | |||
2023 accretion of note discounts | (27,220) | (87,938) | ||
Note discounts issued in conjunction with debt in 2023 | 39,685 | |||
Note discounts as of September 30, 2023 | 37,945 | 25,480 | ||
Convertible notes payable, net, as of September 30, 2023 | 221,740 | $ 194,520 | ||
Effective interest rate | 40% | 10% | ||
Convertible Promissory Note Five [Member] | ||||
Short-Term Debt [Line Items] | ||||
Note discounts as of December 31, 2022 | 14,478 | |||
Note discounts issued in conjunction with debt in 2022 | 44,786 | |||
2023 accretion of note discounts | (15,267) | (30,308) | ||
Note discounts issued in conjunction with debt in 2023 | 17,979 | |||
Note discounts as of September 30, 2023 | 17,190 | 14,478 | ||
Convertible notes payable, net, as of September 30, 2023 | 110,789 | $ 95,522 | ||
Effective interest rate | 28% | 12% | ||
Convertible Promissory Note Six [Member] | ||||
Short-Term Debt [Line Items] | ||||
Note discounts as of December 31, 2022 | 15,951 | |||
Note discounts issued in conjunction with debt in 2022 | 44,787 | |||
2023 accretion of note discounts | (16,741) | (28,836) | ||
Note discounts issued in conjunction with debt in 2023 | 18,020 | |||
Note discounts as of September 30, 2023 | 17,230 | 15,951 | ||
Convertible notes payable, net, as of September 30, 2023 | 110,790 | $ 94,049 | ||
Effective interest rate | 26% | 13% | ||
Convertible Promissory Note Seven [Member] | ||||
Short-Term Debt [Line Items] | ||||
Note discounts as of December 31, 2022 | 9,493 | |||
Note discounts issued in conjunction with debt in 2022 | 22,794 | |||
2023 accretion of note discounts | (9,857) | (13,301) | ||
Note discounts issued in conjunction with debt in 2023 | 8,301 | |||
Note discounts as of September 30, 2023 | 7,937 | 9,493 | ||
Convertible notes payable, net, as of September 30, 2023 | 55,364 | $ 45,507 | ||
Effective interest rate | 24% | 16% | ||
Convertible Promissory Note Eight [Member] | ||||
Short-Term Debt [Line Items] | ||||
Note discounts as of December 31, 2022 | 16,525 | |||
Note discounts issued in conjunction with debt in 2022 | 34,861 | |||
2023 accretion of note discounts | (17,043) | (18,336) | ||
Note discounts issued in conjunction with debt in 2023 | 11,814 | |||
Note discounts as of September 30, 2023 | 11,296 | 16,525 | ||
Convertible notes payable, net, as of September 30, 2023 | 83,018 | $ 65,975 | ||
Effective interest rate | 22% | 18% | ||
Convertible Promissory Note Nine [Member] | ||||
Short-Term Debt [Line Items] | ||||
Note discounts as of December 31, 2022 | 69,569 | |||
Note discounts issued in conjunction with debt in 2022 | 140,289 | |||
2023 accretion of note discounts | (69,569) | (70,720) | ||
Note discounts issued in conjunction with debt in 2023 | ||||
Note discounts as of September 30, 2023 | 69,569 | |||
Convertible notes payable, net, as of September 30, 2023 | 324,500 | $ 271,431 | ||
Effective interest rate | 21% | 21% | ||
Convertible Promissory Note Ten [Member] | ||||
Short-Term Debt [Line Items] | ||||
Note discounts as of December 31, 2022 | 31,788 | |||
Note discounts issued in conjunction with debt in 2022 | 64,104 | |||
2023 accretion of note discounts | (32,367) | (32,316) | ||
Note discounts issued in conjunction with debt in 2023 | 13,200 | |||
Note discounts as of September 30, 2023 | 12,621 | 31,788 | ||
Convertible notes payable, net, as of September 30, 2023 | 110,579 | $ 78,212 | ||
Effective interest rate | 29% | 26% | ||
Convertible Promissory Note Eleven [Member] | ||||
Short-Term Debt [Line Items] | ||||
Note discounts as of December 31, 2022 | 42,506 | |||
Note discounts issued in conjunction with debt in 2022 | 82,500 | |||
2023 accretion of note discounts | (42,939) | (39,994) | ||
Note discounts issued in conjunction with debt in 2023 | 9,900 | |||
Note discounts as of September 30, 2023 | 9,467 | 42,506 | ||
Convertible notes payable, net, as of September 30, 2023 | 82,933 | $ 39,994 | ||
Effective interest rate | 48% | 46% | ||
Convertible Promissory Note Twelve [Member] | ||||
Short-Term Debt [Line Items] | ||||
Note discounts as of December 31, 2022 | 60,126 | |||
Note discounts issued in conjunction with debt in 2022 | 110,000 | |||
2023 accretion of note discounts | (60,705) | (49,874) | ||
Note discounts issued in conjunction with debt in 2023 | 13,200 | |||
Note discounts as of September 30, 2023 | 12,621 | 60,126 | ||
Convertible notes payable, net, as of September 30, 2023 | 110,579 | $ 49,874 | ||
Effective interest rate | 45% | 49% | ||
Convertible Promissory Note Thirteen [Member] | ||||
Short-Term Debt [Line Items] | ||||
Note discounts as of December 31, 2022 | 86,329 | |||
Note discounts issued in conjunction with debt in 2022 | 110,000 | |||
2023 accretion of note discounts | (79,756) | (23,671) | ||
Note discounts issued in conjunction with debt in 2023 | ||||
Note discounts as of September 30, 2023 | 6,573 | 86,329 | ||
Convertible notes payable, net, as of September 30, 2023 | 103,427 | $ 23,671 | ||
Effective interest rate | 22% | 73% | ||
Convertible Promissory Note Fourteen [Member] | ||||
Short-Term Debt [Line Items] | ||||
Note discounts as of December 31, 2022 | 69,678 | |||
Note discounts issued in conjunction with debt in 2022 | 82,500 | |||
2023 accretion of note discounts | (60,250) | (12,822) | ||
Note discounts issued in conjunction with debt in 2023 | 9,900 | |||
Note discounts as of September 30, 2023 | 19,328 | 69,678 | ||
Convertible notes payable, net, as of September 30, 2023 | 73,072 | $ 12,822 | ||
Effective interest rate | 16% | 65% | ||
Convertible Promissory Note Fifteen [Member] | ||||
Short-Term Debt [Line Items] | ||||
Note discounts as of December 31, 2022 | 47,274 | |||
Note discounts issued in conjunction with debt in 2022 | 55,000 | |||
2023 accretion of note discounts | (39,877) | (7,726) | ||
Note discounts issued in conjunction with debt in 2023 | ||||
Note discounts as of September 30, 2023 | 7,397 | 47,274 | ||
Convertible notes payable, net, as of September 30, 2023 | 47,603 | $ 7,726 | ||
Effective interest rate | 14% | 73% | ||
Convertible Promissory Note Sixteen [Member] | ||||
Short-Term Debt [Line Items] | ||||
Note discounts as of December 31, 2022 | 103,463 | |||
Note discounts issued in conjunction with debt in 2022 | 110,000 | |||
2023 accretion of note discounts | (79,754) | (6,537) | ||
Note discounts issued in conjunction with debt in 2023 | ||||
Note discounts as of September 30, 2023 | 23,709 | 103,463 | ||
Convertible notes payable, net, as of September 30, 2023 | 86,291 | $ 6,537 | ||
Effective interest rate | 6% | 73% | ||
Convertible Promissory Note Seventeen [Member] | ||||
Short-Term Debt [Line Items] | ||||
Note discounts as of December 31, 2022 | ||||
Note discounts issued in conjunction with debt in 2022 | ||||
2023 accretion of note discounts | (847,930) | |||
Note discounts issued in conjunction with debt in 2023 | 1,346,539 | |||
Note discounts as of September 30, 2023 | 498,609 | |||
Convertible notes payable, net, as of September 30, 2023 | 719,091 | |||
Convertible Promissory Note Other [Member] | ||||
Short-Term Debt [Line Items] | ||||
Note discounts as of December 31, 2022 | 50,000 | |||
Note discounts issued in conjunction with debt in 2022 | ||||
2023 accretion of note discounts | (50,000) | 50,000 | ||
Note discounts issued in conjunction with debt in 2023 | ||||
Note discounts as of September 30, 2023 | 50,000 | |||
Convertible notes payable, net, as of September 30, 2023 | $ (50,000) | |||
Effective interest rate | ||||
Convertible Promissory Note Seventeen [Member] | ||||
Short-Term Debt [Line Items] | ||||
Effective interest rate | 70% |
CONVERTIBLE PROMISSORY DEBENT_3
CONVERTIBLE PROMISSORY DEBENTURES (Details Narrative) - USD ($) | 1 Months Ended | ||||||||||||||||||||||||||||||||
Sep. 30, 2023 | Jun. 02, 2023 | Dec. 22, 2022 | Dec. 22, 2022 | Nov. 21, 2022 | Nov. 14, 2022 | Nov. 09, 2022 | Oct. 20, 2022 | Sep. 20, 2022 | Sep. 09, 2022 | Aug. 31, 2022 | Jul. 31, 2022 | Jun. 22, 2022 | Jun. 01, 2022 | May 10, 2022 | Apr. 28, 2022 | Mar. 23, 2022 | Oct. 28, 2021 | Oct. 22, 2021 | Oct. 22, 2021 | Oct. 20, 2020 | Sep. 17, 2020 | Sep. 17, 2020 | Jun. 23, 2020 | Jan. 28, 2020 | Jan. 28, 2020 | Aug. 31, 2022 | Oct. 31, 2023 | Sep. 14, 2023 | Dec. 31, 2022 | Nov. 23, 2022 | Aug. 30, 2022 | Jun. 02, 2022 | |
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Aggregate number of warrants to purchase shares | 22,393,561 | ||||||||||||||||||||||||||||||||
Original issue discount amount | $ 285,952 | $ 392,883 | |||||||||||||||||||||||||||||||
Common Stock [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Aggregate number of warrants to purchase shares | 11,196,784 | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Seventeen [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Aggregate principal amount of debt | $ 181,500 | ||||||||||||||||||||||||||||||||
Debt instrument maturity date | Sep. 01, 2024 | ||||||||||||||||||||||||||||||||
Shares issued upon conversion of debt | 1,210,000 | ||||||||||||||||||||||||||||||||
Interest percentage | 0% | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Seventeen [Member] | Osher Capital Partners LLC [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Aggregate principal amount of debt | $ 1,399,200 | $ 181,500 | |||||||||||||||||||||||||||||||
Debt instrument, maturity date, description | January 2024 through September 1, 2024 based on $1.00 for each $0.90909 paid by the previous noteholder | ||||||||||||||||||||||||||||||||
Debt instrument maturity date | Sep. 01, 2024 | ||||||||||||||||||||||||||||||||
Aggregate number of warrants to purchase shares | 9,328,010 | 1,210,000 | |||||||||||||||||||||||||||||||
Exercise price of warrants per share | $ 0.25 | ||||||||||||||||||||||||||||||||
Proceeds from issuance of convertible debt | $ 1,272,000 | ||||||||||||||||||||||||||||||||
Original issue discount amount | $ 127,200 | ||||||||||||||||||||||||||||||||
Debt instrument conversion price per share | $ 0.15 | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Seventeen [Member] | Brio Capital Master Fund Ltd. [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Term of warrants | 5 years | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Sixteen [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Debt instrument maturity date | Dec. 22, 2023 | ||||||||||||||||||||||||||||||||
Interest percentage | 0% | 0% | |||||||||||||||||||||||||||||||
Convertible Promissory Note Sixteen [Member] | Osher Capital Partners LLC [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Aggregate principal amount of debt | $ 110,000 | $ 110,000 | |||||||||||||||||||||||||||||||
Debt instrument maturity date | Dec. 22, 2023 | ||||||||||||||||||||||||||||||||
Term of warrants | 5 years | 5 years | |||||||||||||||||||||||||||||||
Aggregate number of warrants to purchase shares | 733,333 | 733,333 | |||||||||||||||||||||||||||||||
Exercise price of warrants per share | $ 0.25 | $ 0.25 | |||||||||||||||||||||||||||||||
Proceeds from issuance of convertible debt | $ 100,000 | ||||||||||||||||||||||||||||||||
Original issue discount amount | $ 10,000 | $ 10,000 | |||||||||||||||||||||||||||||||
Debt instrument conversion price per share | $ 0.15 | $ 0.15 | |||||||||||||||||||||||||||||||
Debt conversion, description | December 22, 2023 based on $1.00 for each $0.90909 paid by Osher | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Fifteen [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Debt instrument maturity date | Nov. 14, 2023 | ||||||||||||||||||||||||||||||||
Interest percentage | 0% | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Fifteen [Member] | Osher Capital Partners LLC [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Aggregate principal amount of debt | $ 55,000 | ||||||||||||||||||||||||||||||||
Debt instrument maturity date | Nov. 14, 2023 | ||||||||||||||||||||||||||||||||
Term of warrants | 5 years | ||||||||||||||||||||||||||||||||
Aggregate number of warrants to purchase shares | 366,667 | ||||||||||||||||||||||||||||||||
Exercise price of warrants per share | $ 0.25 | ||||||||||||||||||||||||||||||||
Proceeds from issuance of convertible debt | $ 50,000 | ||||||||||||||||||||||||||||||||
Original issue discount amount | $ 5,000 | ||||||||||||||||||||||||||||||||
Debt instrument conversion price per share | $ 0.15 | ||||||||||||||||||||||||||||||||
Debt conversion, description | November 14, 2023 based on $1.00 for each $0.90909 paid by Osher | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Fourteen [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Debt instrument maturity date | Aug. 30, 2024 | ||||||||||||||||||||||||||||||||
Interest percentage | 0% | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Fourteen [Member] | Osher Capital Partners LLC [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Aggregate principal amount of debt | $ 82,500 | ||||||||||||||||||||||||||||||||
Debt instrument maturity date | Nov. 09, 2023 | ||||||||||||||||||||||||||||||||
Term of warrants | 5 years | ||||||||||||||||||||||||||||||||
Aggregate number of warrants to purchase shares | 550,000 | ||||||||||||||||||||||||||||||||
Exercise price of warrants per share | $ 0.25 | ||||||||||||||||||||||||||||||||
Proceeds from issuance of convertible debt | $ 75,000 | ||||||||||||||||||||||||||||||||
Original issue discount amount | $ 7,500 | $ 9,900 | |||||||||||||||||||||||||||||||
Debt instrument conversion price per share | $ 0.15 | ||||||||||||||||||||||||||||||||
Debt conversion, description | November 9, 2023 based on $1.00 for each $0.90909 paid by Brio | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Thirteen [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Debt instrument maturity date | Oct. 20, 2023 | ||||||||||||||||||||||||||||||||
Interest percentage | 0% | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Thirteen [Member] | Osher Capital Partners LLC [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Aggregate principal amount of debt | $ 110,000 | ||||||||||||||||||||||||||||||||
Debt instrument maturity date | Oct. 20, 2023 | ||||||||||||||||||||||||||||||||
Aggregate number of warrants to purchase shares | 733,333 | ||||||||||||||||||||||||||||||||
Exercise price of warrants per share | $ 0.25 | ||||||||||||||||||||||||||||||||
Proceeds from issuance of convertible debt | $ 100,000 | ||||||||||||||||||||||||||||||||
Original issue discount amount | $ 10,000 | ||||||||||||||||||||||||||||||||
Debt instrument conversion price per share | $ 0.15 | ||||||||||||||||||||||||||||||||
Debt conversion, description | October 20, 2023 based on $1.00 for each $0.90909 paid by Osher | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Twelve [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Debt instrument maturity date | Aug. 30, 2024 | ||||||||||||||||||||||||||||||||
Interest percentage | 0% | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Twelve [Member] | Osher Capital Partners LLC [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Aggregate principal amount of debt | $ 110,000 | ||||||||||||||||||||||||||||||||
Debt instrument maturity date | Sep. 20, 2023 | ||||||||||||||||||||||||||||||||
Term of warrants | 5 years | ||||||||||||||||||||||||||||||||
Aggregate number of warrants to purchase shares | 733,333 | ||||||||||||||||||||||||||||||||
Exercise price of warrants per share | $ 0.25 | ||||||||||||||||||||||||||||||||
Proceeds from issuance of convertible debt | $ 100,000 | ||||||||||||||||||||||||||||||||
Original issue discount amount | $ 10,000 | 13,200 | |||||||||||||||||||||||||||||||
Debt instrument conversion price per share | $ 0.15 | ||||||||||||||||||||||||||||||||
Debt conversion, description | September 20, 2023 based on $1.00 for each $0.90909 paid by Osher | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Eleven [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Debt instrument maturity date | Aug. 30, 2024 | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Eleven [Member] | Brio Capital Master Fund Ltd. [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Aggregate principal amount of debt | $ 82,500 | ||||||||||||||||||||||||||||||||
Debt instrument maturity date | Sep. 09, 2023 | ||||||||||||||||||||||||||||||||
Aggregate number of warrants to purchase shares | 550,000 | ||||||||||||||||||||||||||||||||
Exercise price of warrants per share | $ 0.25 | ||||||||||||||||||||||||||||||||
Proceeds from issuance of convertible debt | $ 75,000 | ||||||||||||||||||||||||||||||||
Original issue discount amount | $ 7,500 | 9,900 | |||||||||||||||||||||||||||||||
Debt instrument conversion price per share | $ 0.15 | ||||||||||||||||||||||||||||||||
Debt conversion, description | September 9, 2023 based on $1.00 for each $0.90909 paid by Brio | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Ten [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Debt instrument maturity date | Aug. 30, 2024 | ||||||||||||||||||||||||||||||||
Interest percentage | 0% | 0% | |||||||||||||||||||||||||||||||
Convertible Promissory Note Ten [Member] | Osher Capital Partners LLC [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Aggregate principal amount of debt | $ 110,000 | $ 110,000 | |||||||||||||||||||||||||||||||
Debt instrument maturity date | Aug. 31, 2023 | ||||||||||||||||||||||||||||||||
Aggregate number of warrants to purchase shares | 733,333 | 733,333 | |||||||||||||||||||||||||||||||
Proceeds from issuance of convertible debt | $ 100,000 | ||||||||||||||||||||||||||||||||
Original issue discount amount | $ 10,000 | $ 10,000 | 13,200 | ||||||||||||||||||||||||||||||
Debt instrument conversion price per share | $ 0.15 | $ 0.15 | |||||||||||||||||||||||||||||||
Debt conversion, description | August 31, 2023 based on $1.00 for each $0.90909 paid by Osher | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Ten [Member] | Brio Capital Master Fund Ltd. [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Exercise price of warrants per share | $ 0.25 | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Nine [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Aggregate principal amount of debt | $ 16,500 | ||||||||||||||||||||||||||||||||
Debt instrument, maturity date, description | July 2023 | ||||||||||||||||||||||||||||||||
Shares issued upon conversion of debt | 33,000 | ||||||||||||||||||||||||||||||||
Interest percentage | 0% | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Nine [Member] | Osher Capital Partners LLC [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Aggregate principal amount of debt | $ 16,500 | $ 341,000 | |||||||||||||||||||||||||||||||
Term of warrants | 5 years | ||||||||||||||||||||||||||||||||
Aggregate number of warrants to purchase shares | 676,936 | 649,000 | 33,000 | ||||||||||||||||||||||||||||||
Exercise price of warrants per share | $ 0.50 | ||||||||||||||||||||||||||||||||
Proceeds from issuance of convertible debt | $ 310,000 | ||||||||||||||||||||||||||||||||
Debt instrument conversion price per share | $ 0.50 | ||||||||||||||||||||||||||||||||
Debt conversion, description | July 2023 based on $1.00 for each $0.90909 paid by the noteholder | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Eight [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Debt instrument maturity date | Aug. 30, 2024 | ||||||||||||||||||||||||||||||||
Interest percentage | 0% | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Eight [Member] | Osher Capital Partners LLC [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Aggregate principal amount of debt | $ 82,500 | ||||||||||||||||||||||||||||||||
Debt instrument maturity date | Jun. 22, 2023 | ||||||||||||||||||||||||||||||||
Aggregate number of warrants to purchase shares | 165,000 | ||||||||||||||||||||||||||||||||
Exercise price of warrants per share | $ 0.50 | ||||||||||||||||||||||||||||||||
Proceeds from issuance of convertible debt | $ 75,000 | ||||||||||||||||||||||||||||||||
Original issue discount amount | $ 7,500 | ||||||||||||||||||||||||||||||||
Debt instrument conversion price per share | $ 0.50 | ||||||||||||||||||||||||||||||||
Debt conversion, description | June 22, 2023 based on $1.00 for each $0.90909 paid by Osher | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Seven [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Debt instrument maturity date | Aug. 30, 2024 | ||||||||||||||||||||||||||||||||
Interest percentage | 0% | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Seven [Member] | Osher Capital Partners LLC [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Aggregate principal amount of debt | $ 55,000 | ||||||||||||||||||||||||||||||||
Debt instrument maturity date | Jun. 01, 2023 | ||||||||||||||||||||||||||||||||
Term of warrants | 5 years | ||||||||||||||||||||||||||||||||
Aggregate number of warrants to purchase shares | 110,000 | ||||||||||||||||||||||||||||||||
Exercise price of warrants per share | $ 0.50 | ||||||||||||||||||||||||||||||||
Proceeds from issuance of convertible debt | $ 50,000 | ||||||||||||||||||||||||||||||||
Original issue discount amount | $ 5,000 | 8,301 | |||||||||||||||||||||||||||||||
Debt instrument conversion price per share | $ 0.50 | ||||||||||||||||||||||||||||||||
Debt conversion, description | June 1, 2023 based on $1.00 for each $0.90909 paid by Osher | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Six [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Debt instrument maturity date | Aug. 30, 2024 | ||||||||||||||||||||||||||||||||
Interest percentage | 0% | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Six [Member] | Brio Capital Master Fund Ltd. [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Aggregate principal amount of debt | $ 110,000 | ||||||||||||||||||||||||||||||||
Debt instrument maturity date | May 10, 2023 | ||||||||||||||||||||||||||||||||
Aggregate number of warrants to purchase shares | 220,000 | ||||||||||||||||||||||||||||||||
Exercise price of warrants per share | $ 0.50 | ||||||||||||||||||||||||||||||||
Proceeds from issuance of convertible debt | $ 100,000 | ||||||||||||||||||||||||||||||||
Original issue discount amount | $ 10,000 | 18,020 | |||||||||||||||||||||||||||||||
Debt instrument conversion price per share | $ 0.50 | ||||||||||||||||||||||||||||||||
Debt conversion, description | May 10, 2023 based on $1.00 for each $0.90909 paid by Brio | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Five [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Debt instrument maturity date | Aug. 30, 2024 | ||||||||||||||||||||||||||||||||
Interest percentage | 0% | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Five [Member] | Osher Capital Partners LLC [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Aggregate principal amount of debt | $ 110,000 | ||||||||||||||||||||||||||||||||
Debt instrument maturity date | Apr. 28, 2023 | ||||||||||||||||||||||||||||||||
Aggregate number of warrants to purchase shares | 220,000 | ||||||||||||||||||||||||||||||||
Exercise price of warrants per share | $ 0.50 | ||||||||||||||||||||||||||||||||
Proceeds from issuance of convertible debt | $ 100,000 | ||||||||||||||||||||||||||||||||
Original issue discount amount | $ 10,000 | 17,979 | |||||||||||||||||||||||||||||||
Debt instrument conversion price per share | $ 0.50 | ||||||||||||||||||||||||||||||||
Debt conversion, description | April 28, 2023 based on $1.00 for each $0.90909 paid by Osher | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Four [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Debt instrument maturity date | Aug. 30, 2024 | ||||||||||||||||||||||||||||||||
Interest percentage | 0% | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Four [Member] | Osher Capital Partners LLC [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Aggregate principal amount of debt | $ 110,000 | ||||||||||||||||||||||||||||||||
Debt instrument maturity date | Mar. 23, 2023 | ||||||||||||||||||||||||||||||||
Term of warrants | 5 years | ||||||||||||||||||||||||||||||||
Aggregate number of warrants to purchase shares | 220,000 | ||||||||||||||||||||||||||||||||
Exercise price of warrants per share | $ 0.50 | ||||||||||||||||||||||||||||||||
Proceeds from issuance of convertible debt | $ 100,000 | ||||||||||||||||||||||||||||||||
Original issue discount amount | $ 10,000 | 19,721 | |||||||||||||||||||||||||||||||
Debt instrument conversion price per share | $ 0.50 | ||||||||||||||||||||||||||||||||
Debt conversion, description | March 23, 2023 based on $1.00 for each $0.90909 paid by Osher | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Four [Member] | Brio Capital Master Fund Ltd. [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Aggregate principal amount of debt | $ 110,000 | ||||||||||||||||||||||||||||||||
Debt instrument maturity date | Mar. 23, 2023 | ||||||||||||||||||||||||||||||||
Term of warrants | 5 years | ||||||||||||||||||||||||||||||||
Aggregate number of warrants to purchase shares | 220,000 | ||||||||||||||||||||||||||||||||
Exercise price of warrants per share | $ 0.50 | ||||||||||||||||||||||||||||||||
Proceeds from issuance of convertible debt | $ 100,000 | ||||||||||||||||||||||||||||||||
Original issue discount amount | $ 10,000 | 19,964 | |||||||||||||||||||||||||||||||
Debt instrument conversion price per share | $ 0.50 | ||||||||||||||||||||||||||||||||
Debt conversion, description | March 23, 2023 based on $1.00 for each $0.90909 paid by Brio | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Three [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Debt instrument maturity date | Aug. 30, 2024 | ||||||||||||||||||||||||||||||||
Interest percentage | 0% | 0% | |||||||||||||||||||||||||||||||
Convertible Promissory Note Three [Member] | Osher Capital Partners LLC [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Aggregate principal amount of debt | $ 16,714 | ||||||||||||||||||||||||||||||||
Debt principal amount converted | $ 199,650 | ||||||||||||||||||||||||||||||||
Shares issued upon conversion of debt | 42,857 | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Three [Member] | Osher Capital Partners LLC [Member] | Securities Purchase Agreement [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Term of warrants | 5 years | 5 years | |||||||||||||||||||||||||||||||
Aggregate number of warrants to purchase shares | 8,250 | 8,250 | |||||||||||||||||||||||||||||||
Exercise price of warrants per share | $ 30 | $ 30 | |||||||||||||||||||||||||||||||
Proceeds from issuance of convertible debt | $ 165,000 | ||||||||||||||||||||||||||||||||
Original issue discount amount | $ 16,500 | $ 16,500 | 42,441 | ||||||||||||||||||||||||||||||
Debt instrument conversion price per share | $ 0.39 | $ 0.39 | |||||||||||||||||||||||||||||||
Debt conversion, description | $181,500 aggregate principal amount of Original Issue Discount Senior Convertible Debenture (the “Note”) due September 30, 2021, based on $1.00 for each $0.90909 paid by Osher | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Three [Member] | Osher Capital Partners LLC [Member] | Amended Convertible Debt Agreement [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Debt instrument, maturity date, description | maturity date from October 20, 2021 to October 20, 2022 | maturity date from September 30, 2021 to October 20, 2021 | |||||||||||||||||||||||||||||||
Term of warrants | 5 years | 5 years | |||||||||||||||||||||||||||||||
Aggregate number of warrants to purchase shares | 450,000 | 450,000 | 465,366 | 8,250 | 8,250 | ||||||||||||||||||||||||||||
Exercise price of warrants per share | $ 1 | $ 1 | $ 0.59 | ||||||||||||||||||||||||||||||
Debt instrument carrying amount | $ 199,650 | $ 717,530 | $ 717,530 | $ 652,300 | |||||||||||||||||||||||||||||
Accrued interest | $ 65,230 | ||||||||||||||||||||||||||||||||
Debt principal amount converted | $ 16,714 | ||||||||||||||||||||||||||||||||
Shares issued upon conversion of debt | 42,857 | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Two [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Debt instrument maturity date | Aug. 30, 2024 | ||||||||||||||||||||||||||||||||
Interest percentage | 0% | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Two [Member] | Osher Capital Partners LLC [Member] | Securities Purchase Agreement [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Aggregate principal amount of debt | $ 50,000 | ||||||||||||||||||||||||||||||||
Debt instrument, maturity date, description | maturity date from October 20, 2021 to October 20, 2022 | June 23, 2021 to October 20, 2021 | |||||||||||||||||||||||||||||||
Debt instrument maturity date | Jun. 23, 2021 | ||||||||||||||||||||||||||||||||
Term of warrants | 5 years | 5 years | 5 years | ||||||||||||||||||||||||||||||
Aggregate number of warrants to purchase shares | 450,000 | 450,000 | 10,000 | ||||||||||||||||||||||||||||||
Exercise price of warrants per share | $ 1 | $ 1 | $ 30 | ||||||||||||||||||||||||||||||
Proceeds from issuance of convertible debt | $ 50,005 | $ 50,005 | |||||||||||||||||||||||||||||||
Original issue discount amount | $ 0 | 14,121 | |||||||||||||||||||||||||||||||
Debt instrument conversion price per share | $ 0.39 | ||||||||||||||||||||||||||||||||
Debt conversion, description | June 23, 2021, based on $1.00 for each $0.90909 paid by Osher | ||||||||||||||||||||||||||||||||
Debt instrument carrying amount | $ 717,530 | $ 717,530 | 652,300 | ||||||||||||||||||||||||||||||
Accrued interest | $ 65,230 | ||||||||||||||||||||||||||||||||
Convertible Promissory Note Two [Member] | Osher Capital Partners LLC [Member] | Amended Convertible Debt Agreement Two [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Aggregate principal amount of debt | $ 55,000 | ||||||||||||||||||||||||||||||||
Aggregate number of warrants to purchase shares | 141,020 | ||||||||||||||||||||||||||||||||
Exercise price of warrants per share | $ 0.59 | ||||||||||||||||||||||||||||||||
Original issue discount amount | $ 4,995 | ||||||||||||||||||||||||||||||||
Convertible Promissory Note One [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Debt instrument maturity date | Aug. 30, 2024 | ||||||||||||||||||||||||||||||||
Interest percentage | 0% | 0% | |||||||||||||||||||||||||||||||
Convertible Promissory Note One [Member] | Osher Capital Partners LLC [Member] | Securities Purchase Agreement [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Aggregate principal amount of debt | $ 385,000 | $ 385,000 | |||||||||||||||||||||||||||||||
Debt instrument, maturity date, description | maturity date from October 20, 2021 to October 20, 2022 | ||||||||||||||||||||||||||||||||
Debt instrument maturity date | Jan. 26, 2021 | ||||||||||||||||||||||||||||||||
Term of warrants | 5 years | 5 years | 5 years | 5 years | |||||||||||||||||||||||||||||
Aggregate number of warrants to purchase shares | 450,000 | 450,000 | 80,209 | 80,209 | |||||||||||||||||||||||||||||
Exercise price of warrants per share | $ 1 | $ 1 | $ 7 | $ 7 | |||||||||||||||||||||||||||||
Proceeds from issuance of convertible debt | $ 350,005 | ||||||||||||||||||||||||||||||||
Original issue discount amount | $ 34,995 | $ 34,995 | $ 106,758 | ||||||||||||||||||||||||||||||
Debt instrument conversion price per share | $ 0.094 | $ 0.094 | |||||||||||||||||||||||||||||||
Debt conversion, description | January 26, 2021, based on $1.00 for each $0.90909 paid by Osher | ||||||||||||||||||||||||||||||||
Debt instrument carrying amount | $ 717,530 | $ 717,530 | $ 652,300 | ||||||||||||||||||||||||||||||
Accrued interest | $ 65,230 | ||||||||||||||||||||||||||||||||
Convertible Promissory Note One [Member] | Osher Capital Partners LLC [Member] | Amended Convertible Debt Agreement [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Debt instrument, maturity date, description | maturity date from June 23, 2021 to October 20, 2021 | ||||||||||||||||||||||||||||||||
Exercise price of warrants per share | $ 0.14 | $ 0.14 | |||||||||||||||||||||||||||||||
Interest percentage | 8% | 8% | |||||||||||||||||||||||||||||||
Convertible Promissory Note [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Debt instrument, maturity date, description | October 20, 2021 to October 20, 2022 | ||||||||||||||||||||||||||||||||
Aggregate number of warrants to purchase shares | 450,000 | 450,000 | |||||||||||||||||||||||||||||||
Exercise price of warrants per share | $ 1 | $ 1 | |||||||||||||||||||||||||||||||
Convertible Promissory Note [Member] | Third Party Investor [Member] | Common Stock [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Aggregate number of warrants to purchase shares | 968,000 | ||||||||||||||||||||||||||||||||
Convertible Promissory Note [Member] | Securities Purchase Agreement [Member] | Third Party Investor [Member] | |||||||||||||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||||||||||||
Aggregate principal amount of debt | $ 145,200 | $ 145,200 | |||||||||||||||||||||||||||||||
Debt instrument maturity date | Nov. 21, 2023 | ||||||||||||||||||||||||||||||||
Term of warrants | 5 years | ||||||||||||||||||||||||||||||||
Aggregate number of warrants to purchase shares | 968,000 | ||||||||||||||||||||||||||||||||
Exercise price of warrants per share | $ 0.25 | ||||||||||||||||||||||||||||||||
Proceeds from issuance of convertible debt | $ 132,000 | ||||||||||||||||||||||||||||||||
Original issue discount amount | $ 13,200 | ||||||||||||||||||||||||||||||||
Debt instrument conversion price per share | $ 0.15 | ||||||||||||||||||||||||||||||||
Debt conversion, description | November 21, 2023 based on $1.00 for each $0.90909 paid by the previous noteholder |
ADVANCE FROM SHAREHOLDER (Detai
ADVANCE FROM SHAREHOLDER (Details Narrative) - USD ($) | 9 Months Ended | 12 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | Dec. 31, 2022 | |
Advance From Shareholder | |||
Proceeds from contributed capital | $ 45,000 | $ 0 | |
Proceeds from company advances | 45,000 | $ 0 | |
Proceeds from Loans | $ 0 | $ 0 |
STOCKHOLDERS_ DEFICIT (Details
STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($) | 3 Months Ended | 9 Months Ended | ||||||
Jun. 02, 2023 | Oct. 22, 2021 | Sep. 30, 2023 | Jun. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | Dec. 31, 2022 | |
Class of Stock [Line Items] | ||||||||
Preferred stock shares, authorized | 10,000,000 | 10,000,000 | 10,000,000 | |||||
Preferred stock, par or stated value per share | $ 0.0001 | $ 0.0001 | $ 0.0001 | |||||
Preferred stock shares issued | 1,287 | 1,287 | 0 | |||||
Preferred stock shares outstanding | 1,287 | 1,287 | 0 | |||||
Common stock shares authorized | 1,000,000,000 | 1,000,000,000 | 1,000,000,000 | |||||
Common stock par value | $ 0.0001 | $ 0.0001 | $ 0.0001 | |||||
Common stock shares outstanding | 44,236,260 | 44,236,260 | 38,263,813 | |||||
Number of securities called by warrants | 22,393,561 | 22,393,561 | ||||||
Aggregate principal amount | $ 198,000 | |||||||
Restricted stock | $ 50,000 | |||||||
Share based compensation | $ 37,500 | $ 112,500 | ||||||
Modification of warrants | 226,929 | 226,929 | ||||||
Convertible Promissory Note [Member] | ||||||||
Class of Stock [Line Items] | ||||||||
Number of securities called by warrants | 450,000 | |||||||
Debt maturity date, description | October 20, 2021 to October 20, 2022 | |||||||
Stock issued during period shares | 450,000 | |||||||
Proceeds from issuance of common stock | $ 197,501 | |||||||
Exercise price of warrants per share | $ 1 | |||||||
Other expenses | $ 0 | $ 0 | $ 49,240 | $ 97,939 | ||||
Common Stock [Member] | ||||||||
Class of Stock [Line Items] | ||||||||
Conversion of common stock for Series A preferred stock, shares | (361,809) | (6,105,528) | ||||||
Number of securities called by warrants | 11,196,784 | 11,196,784 | ||||||
Common stock issued to third parties in conjunction with conversion of debt, shares | 1,243,000 | |||||||
Warrant [Member] | ||||||||
Class of Stock [Line Items] | ||||||||
Number of securities called by warrants | 22,393,561 | 22,393,561 | ||||||
Series A Preferred Stock [Member] | ||||||||
Class of Stock [Line Items] | ||||||||
Preferred stock shares issued | 1,287 | 1,287 | ||||||
Conversion of common stock for Series A preferred stock, shares | 6,467,337 | |||||||
Preferred stock conversion, description | Each Series A Convertible Preferred Share converts into one thousand (1,000) shares of the Company’s common stock |
SCHEDULE OF OPERATING LEASE COS
SCHEDULE OF OPERATING LEASE COST AND SUPPLEMENTAL CASH FLOW INFORMATION (Details) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Operating Leases | ||||
Operating lease expense | $ 17,919 | $ 17,919 | $ 53,757 | $ 53,757 |
Short term lease cost | ||||
Total lease expense | $ 17,919 | $ 17,919 | 53,757 | 53,757 |
Operating cash flows from operating leases | 55,941 | 54,312 | ||
Cash paid for amounts included in the measurement of lease liabilities | $ 55,941 | $ 54,312 | ||
Operating lease, weighted average remaining lease term | 2 years 11 months 1 day | 3 years 11 months 1 day | 2 years 11 months 1 day | 3 years 11 months 1 day |
Weighted-average discount rate - operating leases | 10% | 10% | 10% | 10% |
SCHEDULE OF MATURITIES OF OPERA
SCHEDULE OF MATURITIES OF OPERATING LEASE LIABILITIES (Details) - USD ($) | Sep. 30, 2023 | Dec. 31, 2022 | Sep. 30, 2022 |
Operating Leases | |||
2023 (remaining 3 months) | $ 18,954 | ||
2024 | 77,142 | ||
2025 | 79,456 | ||
2026 | 54,224 | ||
Total undiscounted cash flows | $ 229,776 | ||
Operating lease, weighted average remaining lease term | 2 years 11 months 1 day | 3 years 11 months 1 day | |
Weighted-average discount rate | 10% | 10% | |
Lease liabilities, current Present values | $ 201,459 | ||
Lease liabilities—current | 59,061 | $ 53,200 | |
Lease liabilities—long-term | 142,398 | $ 187,425 | |
Lease liabilities—total | 201,459 | ||
Difference between undiscounted and discounted cash flows | $ 28,317 |
OPERATING LEASES (Details Narra
OPERATING LEASES (Details Narrative) - USD ($) | 3 Months Ended | 9 Months Ended | |||||
May 27, 2021 | Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | Dec. 31, 2022 | Jun. 15, 2021 | |
Lease monthly rent | $ 6,134 | ||||||
Operating lease right-of-use assets | $ 180,735 | $ 180,735 | $ 217,718 | ||||
Operating lease liability | 201,459 | 201,459 | |||||
Operating lease cost | $ 17,919 | $ 17,919 | $ 53,757 | $ 53,757 | |||
ASC 842 [Member] | |||||||
Operating lease right-of-use assets | $ 287,805 | ||||||
Operating lease liability | $ 287,805 |
RELATED PARTY TRANSACTIONS (Det
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($) | 3 Months Ended | 9 Months Ended | |||
Apr. 01, 2023 | Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Related Party Transaction [Line Items] | |||||
Stock based compensation | $ 37,500 | $ 112,500 | |||
Mr. Joyce [Member] | |||||
Related Party Transaction [Line Items] | |||||
Stock based compensation | 113,750 | 98,141 | 345,585 | 339,317 | |
Accrued compensation | 113,750 | 31,043 | 174,960 | 31,043 | |
Employment Agreements [Member] | Mr. Joyce [Member] | |||||
Related Party Transaction [Line Items] | |||||
Annual base salary | $ 455,000 | ||||
Maximum bonus compensation percentage | 50% | ||||
Beneficial ownership target percentage | 9% | ||||
Employment Agreements [Member] | Dr Marleau [Member] | |||||
Related Party Transaction [Line Items] | |||||
Maximum bonus compensation percentage | 40% | ||||
Stock based compensation | 75,000 | 0 | $ 151,610 | 0 | |
Accrued compensation | 37,500 | 37,500 | |||
Annual base salary | $ 300,000 | ||||
Percentage of annual increase salary | 3% | ||||
Employment Agreements [Member] | Chief Technology Officer [Member] | |||||
Related Party Transaction [Line Items] | |||||
Stock based compensation | 60,000 | $ 53,562 | 183,288 | 173,678 | |
Accrued compensation | $ 60,000 | $ 103,288 | $ 16,305 |
SCHEDULE OF ANTI DILUTIVE SECUR
SCHEDULE OF ANTI DILUTIVE SECURITIES (Details) - shares | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Total potentially dilutive shares | 24,145,830 | 21,227,623 | 24,489,342 | 21,227,623 |
Convertible Notes Payable [Member] | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Total potentially dilutive shares | 21,847,405 | 9,386,463 | 21,847,405 | 9,386,463 |
Restricted Stock Units (RSUs) [Member] | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Total potentially dilutive shares | 171,756 | 515,268 | ||
Warrant [Member] | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Total potentially dilutive shares | 2,126,669 | 11,841,160 | 2,126,669 | 11,841,160 |
SCHEDULE OF COMPUTATION OF BASI
SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET INCOME PER SHARE (Details) - USD ($) | 3 Months Ended | 9 Months Ended | ||||||
Sep. 30, 2023 | Jun. 30, 2023 | Mar. 31, 2023 | Sep. 30, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Earnings Per Share [Abstract] | ||||||||
Net loss attributable to the common stockholders | $ (905,726) | $ (723,124) | $ (1,341,036) | $ (726,509) | $ (666,325) | $ (678,046) | $ (2,969,886) | $ (2,070,880) |
Basic weighted average outstanding shares of common stock | 44,233,778 | 37,295,813 | 42,031,295 | 37,295,813 | ||||
Dilutive effect of options and warrants | ||||||||
Diluted weighted average common stock and common stock equivalents | 44,233,778 | 37,295,813 | 42,031,295 | 37,295,813 | ||||
Earnings per share, Basic | $ (0.02) | $ (0.02) | $ (0.07) | $ (0.06) | ||||
Earnings per share, diluted | $ (0.02) | $ (0.02) | $ (0.07) | $ (0.06) |
COMMITMENTS AND CONTINGENCIES (
COMMITMENTS AND CONTINGENCIES (Details Narrative) - Mr. Chris Wetzel [Member] | Oct. 10, 2022 USD ($) |
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] | |
Annual payment | $ 30,000 |
Grant restricted stock units | $ 50,000 |
SUBSEQUENT EVENTS (Details Narr
SUBSEQUENT EVENTS (Details Narrative) - USD ($) | Oct. 31, 2023 | Sep. 30, 2023 | Dec. 31, 2022 |
Subsequent Event [Line Items] | |||
Original issue discount amount | $ 285,952 | $ 392,883 | |
Subsequent Event [Member] | |||
Subsequent Event [Line Items] | |||
Original issue discount amount | $ 1,322,200 | ||
Exercise price of warrants per share | $ 0.18 | ||
Issuance of shares | 7,300,342 |